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Abstract 
Group of Uniform Materials Based on Organic Salts (GUMBOS) are a class of molten 
salts that have been focused to be specifically tailored towards applications. Primitively, from 
Davy to Walden molten salts were desirable for organic synthesis due to the properties. 
GUMBOS have been synthesized into nanoparticles (nanoGUMBOS) by various methods to be 
used for lanthanide luminescence and hyperthermal cancer therapeutics. 
Lanthanide photochemistry has been frequently studied for its high luminescence 
intensity, narrow emission band, and stable luminescent lifetime decay. Aerosol-derived 
europium nanoGUMBOS were characterized using electron microscopy (39.5 ± 8.4 nm), XPS, 
and spectroscopic techniques. Spectroscopic measurements indicated intense and steady 
luminescence, which suggests a multitude of possible applications for lanthanide-based 
GUMBOS, especially in sensory and photovoltaic devices. 
Several near infrared (NIR) nanoparticles of GUMBOS composed of cationic dyes 
coupled with biocompatible anions were investigated for their photothermal properties. These 
nanoparticles were synthesized using a reprecipitation method performed at increasing pH 
values. The cations for the nanoGUMBOS, [1048] and [1061], have absorbance maxima at 
wavelengths overlapping with human soft tissue absorbance minima. NIR nanoGUMBOS 
excited with a 1064 nm continuous laser led to heat generation (20.4 ± 2.7 °C) after five minutes. 
While the [1061][Deoxycholate] nanoGUMBOS generated the highest temperature increase 
(23.7 ± 2.4 °C), it was the least photothermally efficient compound (13.0%) due to its relatively 
large energy band gap of 0.892 eV. The energy band gap is a measurement of the HOMO and 
LUMO distance, and predictor of photothermal efficiency. The more photothermally efficient 
 xviii 
 
compound, [1048][Ascorbate] (64.4%), had a smaller energy band gap of 0.861 eV provided an 
average photothermal temperature increase of 21.0 ± 2.1 °C.  
Hyperthermal therapeutics originating from hot pokers has evolved into facilitation of 
NIR nanomaterials photothermal response. NanoGUMBOS can employ a variety of curative 
techniques by pairing fluorescent and biocompatible ions. NanoGUMBOS, [1048][Folate] and 
[1061][Folate], were evaluated using electron microscopy, spectroscopic, thermal imaging, and 
fluorescent assays. In order to generate highly responsive nanomaterials for NIR-laser-triggered 
hyperthermia, optimization of nanoparticle size, shape, and uniformity were investigated. 
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Chapter 1. Introduction 
1.1 Nanotechnology 
1.1.1 Brief Historical Accounts of Nanomaterial Applications 
 Nanomaterials were unknowingly created amidst the fabrication of ruby glass (containing 
gold nanoparticles)
1
 and shears (containing nanorods) during the Roman province of Egypt (30 
BC – 639 AD).2 The nanomaterials in the shears were presently identified to be short rods, or 
grain-like structures, of iron carbonitrides  (i.e. cementite, Fe3C) and martensite.
2-3
 The 
multiwalled carbon nanotubes enveloping cementite nanowires were measured to be about 10 – 
40 nm in diameter (Figure 1.1).
4-5
 These nanomaterials drastically increased the strength of the 
Damascus sword as it was reported that cementite nanowires had a hardness of 12 GPa compared 
to regular steel matrix of 2.5 GPa.
6
 
 
Figure 1.1. Nanowires forged into (A) Damascus swords ranged in (B) several hundred 
nanometers in length and 10 – 40 nm in diameter. Obtained from references 4 and 6 respectively. 
 
1.1.2 Primitive Characterizations of Nanomaterials 
In the early 1900s, materials now referred to as nanoparticles were called “fine particles,” 
“dust/smoke particles,” or “colloids.”7-9 These particles were being researched and observed by 
A B
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spectroscopic techniques (e.g. light scattering),
7
 and measured by extensive calculations
9
 or 
centrifugal methods
10-11
 until a suitable microscope was developed in 1931.
12
 The microscope 
known as the electron microscope was first described as a cathode ray oscilloscope by Max 
Knoll and Ernst Ruska.
13
 A couple of the smoke particles (e.g. ZnO and MgO) and gold particles 
analyzed ranged from 30 to 2000 Å (Figure 1.2). 
 
Figure 1.2. (A) Smoke particles, MgO, (B) fine particles, AuCl3, and, (C) fibers, chrysotile 
asbestos, were imaged with a primitive electron microscope at 20,000 – 50,000 times the 
resolution of the human eye. Obtained from reference 
14
. 
1.1.3 Buckminsterfullerenes and Microtubules 
An American physicist named Richard Feynman proposed the idea of manipulating 
individual atoms to perform mechanical and chemical synthesis in his famous December 29, 
1959  CalTech lecture, “There’s plenty of room at the bottom.”15 Richard Feynman’s lecture is 
considered to be the critical moment when researchers began to take more interest in the sub-
micron world. The hype from his lecture thus began feverish studies of materials in the “very, 
very small world.” The term, “nanotechnology” was coined in 1974 when a Tokyo Science 
University professor, Norio Taniguchi, was describing silicon machining smaller than one 
micron.
16
 
 Presently, the definition of “nano” in the context of materials is any substance that is 
smaller than 100 nm, otherwise materials greater than 100 nm use the prefix “meso.” The first 
article to use the prefix “nano” was titled, “Colloids Distribution Conditions in the 
A B C
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Pharmaceutical Technology: Coacervation, Adsorption, and Micelle Polymerization” in 1976 by 
Swiss researchers at the Federal Institute of Technology in Zurich.
17-18
 Since then, more than 
350,000 articles have been published up-to-date concerning nanomaterials (Figure 1.3). Many of 
these articles on nanomaterials cover a multitude of subject areas from biomedical, sensors, 
lithography, energy conversion and storage, and separations. 
 
Figure 1.3. Nanomaterials to perform work have become of great interest to researchers since 
Iijim’s microtubules in 1991.a 
 
The most popular of all articles concerning nanomaterials (cited ~8,000 times) was the 
discovery and characterization of the ~7 Å buckminsterfullerene, C60, by Richard Smalley in 
1985 from Rice University.
19
 This research was the breakthrough needed for Sumio Iijima to 
characterize the C60 cousin, the helical graphitic carbon “microtubules” in 1991 (Figure 1.4).
20
 
Today, Iijima’s premier article on ~5.5 – 6.7 nm diameter carbon nanotubes has been referenced 
over 13,000 times. With the synthesis of the C60 and carbon “microtubules,” researchers began to 
synthesize nanostructures of variable shapes and of different components for mechanical 
purposes. 
                                                          
a
 Histogram was derived from article frequency searching the following key phrases in the "Web of Knowledge" 
database: nano -wire, -particle, -tube, -shell, -drop, -film, -caps. 
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Figure 1.4. Graphitic carbon microtubules that were discovered by Iijima in 1991 had varying 
diameters and layers: [a] 6.7 nm five-sheet, [b] 5.5 nm two-sheet, and [c] 6.5 nm (2.2 nm internal 
diameter) seven-sheet. Obtained from reference 
20
. 
 
1.1.4 Nanomaterials Synthesis 
 The synthesis of carbon nanostructures was the ignition needed for researchers to 
manipulate materials into the nanoscale. Carbon nanotubes (CNTs) are studied as either single-
walled (SWCNT) or multi-walled (MWCNT). The excitement behind these sp
2
 carbon structures 
is due to the application versatility, abundance, ease of synthesis, and physical properties.
21-23
 
Comprehensive research of CNT applications is in biomedical,
24-25
 energy conversion,
26-27
 
circuits,
28
 composites,
29
 and chemical sensing.
30
 Excitement over CNTs physical properties is the 
driving force for research on these multifaceted carbon graphene tubes.
22, 31
 These properties 
would include 20 times the tensile strength of steel at 300 GPA
32
 and more efficient electrical 
conductivity.
33
 
The discovery and overwhelming use of graphene nanomaterials led researchers to 
manipulating other compounds into the nanoregime to perform mechanical work. Other than 
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graphene, silica and gold have been studied more than 60,000 and 55,000 times since 1989, 
respectively. The other common compounds synthesized into nanomaterials include: metal 
complexes (i.e. silver, copper, iron oxides), metal alloys (CdSe/ZnS, CdTe1-XSeX), liposomes, 
micelles, dendrimers, and polymer.
34
 These compounds were synthesized into nanomaterials by 
various methods: laser ablation,
35
 electric arc discharge,
36
 vapor deposition,
37
 aerosol,
38
 
electrospinning,
39
 templating, seeding, reprecipitation, emulsion, and surfactant-based.
37, 40
 
1.1.5 Aerosol and Reprecipitation Nanoparticle Techniques 
1.1.5.1 Aerosol Nanoparticle Technique 
 
Figure 1.5. The aerosol method of fabricating nanoparticles is made up of eight components (A) 
air filter and pressure control, (B) nebulizer and sample reservoir, (C) silica gel dryer to remove 
moisture, (D) electrostatic classifier to neutralize the particles, (E) oven to dry off solvent, (F) 
flow direction valve, (G) sample collection onto a membrane, and (H) particle size & counter. 
 
The various aforementioned methods in which to fabricate nanomaterials continues to be 
aggressively researched (including an attempt by the author) throughout academia and industry. 
However, in regards to this monograph, methods to synthesize nanoparticles were performed by 
aerosol and co-precipitation methods. Fabrication of nanoparticles by aerosol is a relatively 
facile exercise as long as the instrumental setup is properly installed (Figure 1.5). The bulk 
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sample must first be dissolved and connected to a nebulizer. The air pressure and oven is 
adjusted to optimize the size of nanoparticles. The solution of the material is placed under 
pressure to nebulize through a chamber connected to a moisture drying component. The air 
pressure continuously carries the nebulized solvent through an oven to dry off the solvent before 
being collected onto a membrane filter. 
1.1.5.2 Sonochemical Reprecipitation Nanoparticle Technique 
Reprecipitation methods for synthesizing nanoparticles have various techniques with the 
intent on precipitating the desired nanoparticles. These diverse procedures that have been 
attempted use two solvents for precipitation methods include (1) two miscible solvents with a 
sample that is soluble in one of the solvents, (2) two immiscible solvents with a sample that is 
soluble in one of the solvents, and (3) two immiscible solvents with soluble reactants that 
become insoluble in both solvents as a product. The reprecipitation method (1) was found to 
yield the more spherical and polydisperse nanoparticles, especially when assisted by an 
ultrasonic sonicator. This particular method is performed by dissolving the sample (e.g. in 
acetone), and then adding a small aliquot of the sample to the miscible/insoluble solvent (e.g. 
water). The insoluble sample gravitates toward cavitation (“bubble”) sites which are created 
during sonication (20 kHz to 100 MHz).
41
 Nanoparticles are formed when chemical bonds break 
(less than a nanosecond) resulting in the “bubble” collapsing. Crystallization of nanoparticles 
does not usually occur due to the high cooling rate. Another instrument which was used along 
with the reprecipitation method (1) was a microwave apparatus. 
1.1.5.3 Microwave Reprecipitation Nanoparticle Technique 
Microwave irradiation employs internal heating of a sample by two different ways: 
dipolar polarization and ionic conduction.
42
 Dipolar polarization is the process of polar 
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solvent/reagents aligning to the microwave frequency (2.45 GHz) of the applied electric field. 
Oscillation of the alternating electric field forces the molecules to constantly realign resulting in 
molecular friction and dielectric heating. The microwave frequency of 2.45 GHz is the optimum 
frequency for molecules to not realign too quickly (lower frequency) or slowly (higher 
frequency) which would lead to insufficient heating. The other mode of heating by microwave 
irradiation, ionic conduction, is from charged particles in the sample. The ionic particles 
influenced under the alternating applied electric field create collisions with other particles 
resulting in heat.  
The amount of thermal energy that samples and solvent create to uniformly heat a 
solution can be theoretically determined from the loss tangent factor (tan δ).  
     
                         
                       
    Equation 1.1 
This ratio of the efficiency of microwave frequency [converted to thermal energy (e’’)] and the 
polarity of the molecules (e’) provides an expression of the efficiency of electric absorption and 
heating. Generally, the more polar solvents have a higher loss tangent than lesser polar solvents 
when measured at room temperature (Table 1.1).
42
 A study of the loss tangent at temperatures 
higher than a solvents boiling point revealed a decrease in the solvents capability to absorb and 
heat. Ethanol decrease in tan δ is attributed to the solvents change in viscosity (i.e. liquid-to-gas 
phase change), thus reducing friction from the molecules attempting to align with the applied 
electric field under dipolar polarization heating. Alternative solvents such as ionic liquids (vide 
infra), 1-butyl-3-methylimidazolium hexafluorophosphate or [Bmim][PF6], are heated from ionic 
conduction due to being composed of charged ions. Friction among the molecules aligning to the 
electric field will not decrease due to a lack in boiling point for ionic liquids. Ionic liquids are 
efficient absorbers of heat and microwave frequencies among other extensive useful properties. 
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Table 1.1. The loss tangent is a function of a solvent’s ability to absorb and convert energy into 
heat. 
 
1.1.6 Applications of Nanomaterials 
Since Richard Feynman’s inspirational talk, there have been numerous task-specific 
nanomaterials performing work. The most common nanomaterial, carbon nanotubes (CNTs), has 
been used in scientific research ranging from energy
43
 to biomedical.
44
 Energy research, such as 
optoelectronics, circuits, and thermoelectrics, was conducted using CNTs because of the high 
thermal (6 kW K
-1
 m
-1
)
45
 and electrical conductivities (2.5 – 4.0 kS m-1).46 Biomedical research 
using CNTs comprised of functional compounds (e.g. fluorescent, magnetic, cancer-killing, or 
biocompatible). In order to synthesize functional compounds covalently to pristine CNTs, the 
graphene microtubulars were oxidized by an acidic solution (e.g. HNO3) to create carboxylic 
acid sites. 
 Another widely used nanomaterial is gold nanoparticles. Gold nanoparticles have been 
functionalized by reduction of gold (III) in a thiol solution. Functionalized gold nanoparticles 
have been used as biomarkers and for biomedical therapeutics.
1
 Gold nanoparticles inherently 
have a Mie scattering excitation peak around 530 nm and surface plasmon absorption in the near 
infrared spectrum (700 – 1000 nm). A change in diameter for gold nanoparticles will shift the 
surface plasmon absorption wavelength either red or blue (larger or smaller particles, 
respectively). 
at 20 °C at 100 °C at 200 °C
Solvent tan δ
Ethanol 0.941 0.270 0.080
DMSO 0.825 - -
Methanol 0.659 - -
[BMIM][PF6] 0.185 1.804 3.592
DMF 0.161 - -
Water 0.123 - -
Acetonitrile 0.062 - -
Acetone 0.054 - -
Toluene 0.040 - -
Hexane 0.020 - -
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Gold nanoparticles and CNTs have been extensively used in biomedical research as 
biomarkers and/or drug delivery. An example of these nanomaterials used in therapeutics is 
hyperthermia for the destruction of cancerous tumors. The nanomaterials would absorb and 
release thermal energy (~42 – 60 °C) when irradiated by a near infrared laser. 
1.1.7 Microscopy of Nanomaterials 
 
Figure 1.6. Traditional and transmission electron microscopes have similar instrumentation 
design. 
The most common instrument to observe nanomaterials is a transmission electron 
microscope (TEM). TEM uses an electron gun as an “illuminating source” to be able to produce 
electron micrographs as seen in figures 1.1, 1.2, and 1.4. Electron guns are capable of producing 
5 – 400 keV which is proportional to higher resolution and magnification of nanomaterials. 
Similar to traditional microscopes, the sample specimen for TEM is close to the “light source” 
(Figure 1.6). The sample is drop-casted onto a carbon grid (usually copper coated) and placed in 
a high vacuum prior to electron gun irradiation. The sample absorbs electrons during electron 
gun irradiation while the electrons not in the path of the sample pass freely to the fluorescent 
screen. 
Electron Gun
Condenser Lens
Sample
Objective Lens
Objective
Aperture Lens
Intermediate Lens
Projector Lens
Illuminating Source
Fluorescent
Screen
Ocular Lens Lens
Detector
Lamp
Traditional Transmission Electron
Eye
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1.2 Molten Salts to GUMBOS 
1.2.1 Ionic Liquid Overview 
Scientific research interests occur cyclically due to reoccurring curiosity from new-
supporting discoveries. Molten organic salts are not any different from this happenstance. Over 
centuries molten salts
47
 have been called sirups [sic],
48
 oils,
49
 ionic liquids (IL),
50
 room 
temperature ionic liquids (RTIL),
51-52
 organic ionic liquids (OILs),
53
 frozen ionic liquids (FIL),
54-
55
 and a group of uniform materials based on organic salts (GUMBOS).
56
 In order to learn the 
origin of these “green” compounds it is first necessary to list the characteristics.57-59 Presently, 
the definition of ionic liquids are molten salts with a defined melting point less than 100 
o
C.
60
 
Sodium chloride is considered a molten salt above 800 
o
C, when the cubic crystal lattice breaks 
down and becomes a liquid.
61
 Ionic liquids and molten salts have been defined to have low 
volatility, conductive, and have high thermal stability.
62-64
 In the past, ionic liquids were defined 
to be nonflammable; however, in 2008 the research time led by Ghanshyam Vaghjiani from 
Edwards Air Force Base research lab blended hypergolic ionic liquids with bipropellant rocket 
fuel to increase the oxidizing agent reactivity and lower volatility.
65
 Organic salts with relatively 
low melting points are due to poor crystal packing, charge delocalization, and cation-anion 
asymmetry. 
1.2.2 Brief Account of Ionic Liquid Origin 
Paul Walden, a Latvian born research chemist, is credited for reporting the first ionic 
liquid.
47
 Walden purposefully synthesized his ionic liquid, ethyl ammonium nitrate, by an acid-
base neutralization technique.
66
 An acid-base neutralization involves addition of a Brønsted acid 
to a Brønsted base in a chilled aqueous solution (Scheme 1.1).
67
 He needed a solvent that could 
be heated with negligible vapor pressure and therefore looked towards the low melting 
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temperature salt (i.e. 12 °C). These low melting “solvents” would not be presented again until 
1948 by Hurley and Wier.
68
 In brief, their research consisted of pyridinium halides salts fused 
electrolytically with metallic chlorides. They concluded that a ~10-75 mole % of fused metallic 
chlorides (i.e. AlCl3) with pyridinium halides lowered the melting point of the salt below 100 °C, 
thereby making it a doped ionic liquid (Figure 1.7). 
Scheme 1.1. A neutralization method consisting of a Brønsted acid and base was used to 
synthesize ionic liquids. 
 
 
Figure 1.7. Phase diagram of different mole percent ratios of aluminum chloride fused with ethyl 
pyridinium bromide, AlCl3:[Etpyr][Br], shows a variable melting point trend (1:2 = 45 °C, 1:1 = 
88 °C, and 2:1 = -40 °C). Obtained from reference 
68
. 
 
In 1982 John S. Wilkes introduced the imidazolium ionic liquid as an electrolyte for his 
electrochemical studies.
52
 The imidazolium was a great discovery for ionic liquid research 
because of inefficient molecular packing resulting in a low melting point. Wilkes performed 
metathesis reactions (anion exchange) a decade later to the ionic liquid, [1-ethyl-3-
methylimidazolium][iodide] with one of the following anions: NO2, NO3, BF4, MeCO2, and 
SO4·H2O.
69
 The demonstration of exchanging the metal halide anion resulted in air and moisture 
CH3CH2NH2 + HNO3 CH3CH2NH3
+ +  -NO3
 12 
 
stable ionic liquids without spontaneously forming hydrates.
70
 Exchanging counterions is the 
synthesis used to produce designer ionic liquids for a myriad of applications (Scheme 1.2). This 
new door of ambient stable ionic liquids gave rise to a multitude of functional uses, research 
areas, and spectacular findings (Figure 1.8). 
Scheme 1.2. A facile metathesis reaction of ionic liquids and like compounds allow for tailor-
made materials. 
 
 
 
Figure 1.8. Research interest was low for these salts until Wilkes demonstrated metathesis with 
organic anions in his 1992 article.
b
 
1.2.3 Applications of Ionic Liquids 
Six years after Wilkes astonished the ionic liquid research community with the metathesis 
reaction, arguably the first ionic liquid for a practical application was presented.
53
 The ionic 
liquid for practical purposes, or task-specific ionic liquid (TSIL), was [Miconazole][PF6] an 
antifungal drug. Although demonstration of the antifungal ionic liquid was never fully realized, 
task-specific ionic liquids were on the horizon. Presently, ionic liquids are mostly being used for 
the following properties: separations, electrochemical, negligible volatility solvent, and 
catalysis.
71-73
 
                                                          
b
 Histogram was derived from article frequency searching the following key phrases in the "Web of Knowledge" 
database: ionic liquids and molten salts. 
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1.2.4 Group of Uniform Materials Based on Organic Salts 
 
Figure 1.9. Properties and fabrication of GUMBOS and nanoGUMBOS have many 
opportunities. 
 
A newer classification of molten salts simulating properties of ionic liquids was coined as 
a Group of Uniform Materials Based on Organic Salts, or GUMBOS. These GUMBOS simulate 
ionic liquid properties except for functional use in the solid-state phase and the melting point 
range of 25 – 250 °C. A new term to describe these task-specific molten salts was needed due to 
the many interesting properties and applicable uses of molten salts in the solid-state phase. In 
early 2008, Aaron Tesfai under the guidance of Isiah Warner published the first paper 
concerning this new class of molten salts titled, “Controllable Formation of Ionic Liquid Micro- 
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and Nanoparticles via a Melt-Emulsion-Quench Approach.”55 Since this novel concept of having 
organic salts perform work, this research group has demonstrated seven applications for the 
newly-defined GUMBOS technology
38, 56, 74-78
 and eight applications for traditional ionic liquids 
(Figure 1.9).
55, 79-85
 
Scheme 1.3. GUMBOS synthesis using (A) Lewis acid and base method for 1-Butyl-2,3-
dimethylimidazolium chloride and (B) SN2 reaction for quaternization of hypergolic ionic 
liquids. Obtained from references 
56
 and 
86
. 
 
 
 
Synthesis of GUMBOS includes the aforementioned methods and the following: 
combination of a Lewis acid and base, and quaternization. The Lewis acid and base synthesis 
was used to fabricate magnetic nanoGUMBOS (Scheme 1.3A).
56
 The quaternization of an amine 
was performed by alkylation of tertiary amines to produce ionic liquids (Scheme 1.3B).
86-87
 
Task-specific molten salt technology is not new in a sense of concept (vide supra),
53
 but 
new life has been restored in the realization of many possibilities. A few of the molten salt 
applications with combinatorial properties using GUMBOS and TSIL technology are the 
following: magnetic and chiral,
80
 fluorescent and chiral,
81
 protic and chiral,
82
 and magnetic, 
luminescent, and tumor-targeting.
85
 Herein this dissertation are a few research projects that 
exemplify these task-specific ionic liquid-like salts. 
A
B
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1.2.4.1 Organic Salts Applications 
Organic salts, such as GUMBOS have been demonstrated for purposes other than 
electrochemical or separations. The nanoGUMBOS consisting of [1,1’,3,3,3’,3’-
Hexamethylindotricarbocyanine] [bis(2-ethylhexyl)sulfosuccinate] administered biocompatible 
infrared fluorescence characteristics.
74
 The nanoGUMBOS ranged in sizes of 71 ± 16 nm easily 
penetrated within a monkey kidney fibroblast cell after 24 hour incubation. The nanoGUMBOS 
fluorescence resulted in a blue shift relative to dissolved bulk GUMBOS. A fluorescent 
microscope was used to image the nanoGUMBOS inside the cells. 
Magnetic chiral GUMBOS was another study showing the vast opportunities that these 
novel compounds can possess.
80
 The GUMBOS were derived from chiral amino acid cations and 
iron (III) chloride anion. Four different amino acid cations were studied to observe the influence 
onto the magnetic moment and fluorescence of the GUMBOS. The enantiomers had a difference 
in fluorescence intensity making these compounds viable for asymmetric catalysis and synthesis. 
1.3 Rare Earth Metals 
1.3.1 Background of Rare Earth Metals 
 
Figure 1.10. Mendeleev’s attempt to of the periodic table shows confusion of where to place the 
lanthanide elements. Obtained from reference 
88
.
c
 
                                                          
c
 In regards to rare earths, the listed element Didymium (Di) was later found to be a lanthanide metal complex of 
both Praseodymium and Neodymium; and atomic symbol for Yttrium has changed from Yt to Y.  
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Rare earth metals are synonymously called lanthanides due to the first element in the 
respective row of the periodic table of elements, lanthanum. The lanthanide elements were given 
a separate row on the periodic table due to confusion of placement. The lanthanides troubled the 
creator of the table of elements, Dimitri Mendeleev, when he situated the elements according to 
atomic weight and properties in 1869.
89
 In Figure 1.10, question marks next to the known 
lanthanides can be seen due to his confusion.
88
  
 Lanthanides are the first of the elements to have f-orbitals (Figure 1.11), experience 
lanthanide contractions (atomic radii decreases with increasing atomic number), and combined 
strong magnetic and luminescent behavior. The f-orbitals are smaller than the larger radial closed 
5s and 5p orbitals, and thus are strongly shielded. This shielding protects lanthanides from 
solvation effects which would broaden and/or shift the photophysical spectrum from variable 
environments. 
 
Figure 1.11. The atomic orbitals (s, p, d, and f) in Cartesian coordinates with magnetic quantum 
numbers, ml, are listed from largest to smallest. 
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1.3.2 Luminescence Spectroscopy of Rare Earth Metals 
The luminescence of lanthanides has been researched for nearly 90 years since 
Tomaschek and Deutschbein first studied the spectral lines, phosphorescence properties, and 
involvement of the f-orbitals in 1924.
90-91
 Contribution of the f-orbitals to lanthanide luminescent 
behavior leads to an increase in quantum yield, long radiative lifetime (phosphorescence), and 
narrow luminescence intensity. Trivalent lanthanides cannot be directly excited to produce 
luminescence due to the higher-lying filled 5s and 5p orbitals, and thus rely on excitation transfer 
to the f-orbitals.
d
 The f-orbitals of the lanthanides must be directly excited to employ these 
properties by ways of Förster resonance energy transfer (FRET) or ligand-to-metal charge 
transfer (LMCT). This antenna effect (excitation transfers) follows a system of nonradiative 
pathways to lanthanide energy levels ultimately leading to large red-shift and intense 
luminescence. The importance of the antenna effect to surpass the spin-forbidden transition was 
observed 20 years after luminescence from lanthanides were discovered for europium in 1942 by 
Weismann.
92
 The red-shift, as observed by Sir George Gabriel Stokes in 1852, is typical with 
emission as the excitation energy put into a luminescence compound is greater than the output.
93
 
In addition, Niels Bohr in communication with Ernest Rutherford produced a solar system model 
of the atom and spectral lines (energy levels) in 1914.
94-96
 These conjoined theories led to 
Aleksander Jabloński’s famous diagram to explain electron promotion upon excitation and 
relaxation emission (Figure 1.12).
97-98
 Jabloński introduced the diagram as a simplistic way of 
explaining phosphorescence of fluoresceine. In his diagram, the energy levels N stood for normal 
state, M for metastable state, and F for fluorescing state. The actions represented a for 
                                                          
d
 The concept of orbital filling depends heavily on the Aufbau (“building up” of electrons to postulate an atoms 
outer most orbital shells) and Pauli exclusion (no two electrons of the same spin can occupy the same space) 
principles. 
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absorption, b for fluorescence, c for transition to metastable state, d for thermoexcitation, e and f 
for phosphorescence, and g for slight probability of absorption.  
 
Figure 1.12. Jabloński’s (A) original diagram98 in 1933 and (B) modern diagram ~80 years later 
both similarly show a visualization for luminescence studies. 
 
Figure 1.13. A Jabloński diagram is used to represent lanthanide (i.e. europium) emission via 
antenna effect. (Note: Relaxation energies are not to scale.) 
 
The spectroscopic profiles of lanthanides are unlike most organic fluorophores, in that 
each energy level for absorbance or luminescence is depicted on the spectrum (Figure 1.13). 
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Unlike organic or transition metal absorbance spectra, lanthanides appear as atomic spectra as 
the multiple 4f-4f energy level transitions are visible (Figure 1.14).
99
 In addition to the spectral 
lines being visible, the higher-lying 5s and 5p orbitals protect from solvent luminescent 
quenchers. Luminescent quenchers ultimately reduce the emission quantum yield of a 
fluorophore. Static quenchers can affect luminescence by inhibiting excitation energy, or altering 
the absorbance spectrum by complexing with the luminescent molecule. The following are 
examples of dynamic quenchers (and cause): collisional (solvent or paramagnetic/dissolved 
oxygen), heavy atom effect (halogens and other electron scavengers; protons, NO3
-
, Cu
2+
, Pb
2+
, 
Cd
2+
, and Mn
2+
), excimers (unstable dimers changing excitation/emission spectrum), and FRET. 
Otto Stern and Max Volmer devised an equation to describe luminescent quenching in 1919:
100
 
  
 
           Equation 1.2 
The pair established, KSV as the Stern-Volmer quenching constant equaling to the product of the 
bimolecular quenching constant, kq, and lifetime of the fluorophore without quencher, τ0. 
Fluorescence intensities with and without quencher were respectively assigned as F and F0. 
 
Figure 1.14. Photophysical spectra of europium (Eu
3+
) reveals energy level term symbols for 
absorbance and luminescence. (I.) Spectra of aqueous 0.100 M EuCl3 for absorbance and 0.8 µM 
Eu(thenoyltrifluoroacetone)3 · 2H2O in acetonitrile for luminescence. (II.) and (III.) are enlarged 
regions of spectra for absorbance and luminescence, respectively. 
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A set of rules were devised in the 1925 by Friedrich Hund for ground state energy level 
(quantum) transitions to be written.
101
 These three consecutive set of rules that rightfully came to 
be known as Hund’s rule are as follows: 
(1) the ground state term has the largest spin multiplicity, 
(2) largest orbital multiplicity,  
(3) if number of electrons, n < 2(ML)+1 then J = Jmin, but if n > 2(ML)+1 then J=Jmax. 
The electronic configuration for the lanthanides is written with term symbols, 
2S+1ΓJ, that derive 
from ML and MS quantum numbers.
102
 The total orbital and spin quantum numbers, ML and MS, 
are the respective sums of ml and ms. The term symbols designate ML and MS as angular 
momentum Γ (orbital) and S (spin) quantum numbers, respectively. The orbital angular 
momentum quantum number, Γ, is appointed by the following quantum letters: S, P, D, F, G, … 
(alphabetically excluding J thereafter) corresponding to ML (0, 1, 2, 3, 4, …). The spin angular 
momentum quantum number, S, is the product of the number of electrons in the outermost 
subshell and ½ electron spin. The product of spin multiplicity, 2S+1, and orbital multiplicity, 
2ML+1, is the number of possible microstates (or atomic states). The total angular momentum 
quantum number, J, is the sum of the orbital angular and spin angular momentum quantum 
numbers. From these calculations the ground state terms for trivalent lanthanides can be 
determined (Table 1.2). 
Table 1.2. Ground state term symbols for trivalent lanthanides according to Hund’s rule. 
 
Lanthanide 
Atomic Symbol
fn
Ground State 
Term
La Lu f0 f14 1S0
1S0
Ce Yb f1 f13 2F5/2
2F7/2
Pr Tm f2 f12 3H4
3H6
Nd Er f3 f11 4I9/2
4I15/2
Pm Ho f4 f10 5I4
5I8
Sm Dy f5 f9 6H5/2
6H15/2
Eu Tb f6 f8 7F0
7F6
Gd f7 8S7/2
 21 
 
1.3.3 Instruments for Spectroscopy 
1.3.3.1 Absorption Spectrometry 
Molecular absorbance can be measured by an ultraviolet-visible-near-infrared (UV-Vis-
NIR) absorbance instrument (Figure 1.15). The absorbance instrument uses a light source (e.g. 
xenon arc, tungsten filament, and deuterium lamps) to promote a sample’s electron from the 
highest occupied molecular orbital (HOMO) to the lowest unoccupied molecular orbital 
(LUMO). Electron promotion to a molecular orbital is typically referred to as excitation from the 
singlet ground state (S0) to the first excited singlet state (S1) and occurs at a rate of picoseconds 
to femtoseconds.  
 
Figure 1.15. A typical double-beam absorbance instrument was used to measure the absorbance 
of the solute in solvents. 
The absorbance instrument measures the electronic transitions by filtering selected 
wavelengths from the light source by a monochromator. The light is then split into two by 
mirrors to have one-half of the beam measure absorbance from the reference cell, and the other 
half measuring the sample. The two results are detected by transducers (e.g. photomultiplier tube 
or photodiode) and compared by a difference amplifier measuring the solute absorbance with 
respect to the solvent. The spectrum is then displayed onto an output device (e.g. computer or 
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light-emitting diode (LED) display). A mathematical representation of absorbance spectroscopy 
is expressed through the Beer-Lambert Law. 
             
  
 
        Equation 1.3 
The Beer-Lambert Law indicates that absorbance (A) is inversely proportional to the log 
of transmittance (T). Since absorbance is the amount of light that is used to promote a solution to 
an excited state, intuitively transmittance is the amount of light that traverses through a solution. 
To measure the amount of light taken up by solution Lambert’s law states that the log ratio of 
incident light from the source (I0) is compared to the incident light that passed through the 
solution (I). Lastly, the more common usage of Beer’s Law is the product of molar absorptivity 
(ε), cell path length (b), and sample concentration (c). Beer’s Law can be used to quantitatively 
acquire an unknown concentration after performing a series of known concentrations resulting in 
a plotted calibration curve (y=mx+b). The slope (m) of the curve would equate to molar 
absorptivity (ε). 
1.3.3.2 Photophysical Spectrometry 
Luminescence is the radiative relaxation, called emission, of an electron from an excited 
state to ground state. In order for the luminescence to occur for organic molecules, the molecule 
must contain an aromatic compound that is conjugated (e.g. anthracene) or attached to a 
conjugated double bond (e.g. cyclanone). The radiative transitions can labeled as “spin-allowed” 
when the electron spin multiplicity is not changed during excitation or emission, such as singlet 
to singlet (S0→Sn or S1→S0, respectively). A radiative transition called, “spin-forbidden” is 
when the spin multiplicity is changed during excitation or emission. Spin-forbidden transitions 
during excitation usually result in a weak molar absorptivity; however, during emission these 
transitions take relatively longer to reach ground state than spin-allowed transitions. Emission 
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from a spin-allowed transition is referred to as fluorescence and can have radiative lifetimes 
ranging from microseconds to nanoseconds. Contrastingly, spin-forbidden transitions are 
referred to as phosphorescence and can have long radiative lifetimes ranging from milliseconds 
to seconds. Long-lived or delayed fluorescence is similar to phosphorescence having long 
radiative lifetimes, but the radiative relaxation occurs from the excited singlet state opposed to 
excited triplet state as depicted in a Jabloński diagram (figure 1.12B). 
 
Figure 1.16. Spectrofluorometer instrument is used to measure the luminescence intensity from a 
sample. 
 
Luminescence spectra are acquired by a light source (e.g. xenon arc lamp or Nd:YAG 
laser) shining through a monochromator (wavelength selector) exciting the sample (Figure 1.16). 
The excitation wavelength typically is the absorbance wavelength maximum. The excitation 
wavelength is then measured as a reference of light intensity and later compared to the samples 
emission intensity. The excitation light towards the sample passes through apertures (or slits) to 
control excitation light intensity. The apertures are adjusted (1 – 10 nm) depending on whether 
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the sample requires more light due to being too diluted, or less light due to being over 
concentrated. The sample cell is excited orthogonally from the detector to avoid light source 
saturation. The resulting emission passes through another aperture that controls the intensity to 
the photomultiplier tube. The emission spectrum with respect to the reference is displayed onto 
an output device. 
Emission from a sample is usually incapable of achieving a 100% quantum emission 
yield due several factors. The factors disallowing a 100% quantum yield would include 
photobleaching, collisional quenching, heavy-atom effects, dynamic quenching, and radiationless 
processes. The radiationless processes encompass internal conversion (S1 → S0 + heat, or T1 → 
S0 + heat) and intersystem crossing (S1 → T1 + heat). In the succeeding sections (1.4) the heat 
produced from inefficient luminescence is important towards photothermal generation for cancer 
destruction. 
1.3.4 Applicable Uses of Rare Earth Metals 
 Since the understanding of lanthanide properties there have been many practical uses for 
medical and commercial purposes. The earliest use for a trivalent lanthanide, europium, was in 
cathode-ray tube television (CRT) screens.
103
 By using the intense luminescent behavior of 
europium, television manufacturers were able to make the image more vibrant. These 
luminescent properties are currently be studied by various academic, government, and 
independent research facilities mainly to work as biomarkers.
104
 Various rare earth metal 
complexes are currently in use for cancer patients under the drug brand names (lanthanide): 
Antrin (lutetium), Optrin (lutetium), and Omniscan (gadolinium).
105
 The drugs listed are for the 
following purposes, respectively: removal of plaque in the artery, macular degeneration, and as a 
magnetic resonance imaging (MRI) contrast agent.
106
 Lutin is a drug that employs lutetium for 
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cancer therapy by creating singlet oxygen (
1
O2) from photodynamic irradiation at 732 nm. 
Singlet oxygen species are generated during relaxation of triplet state after excitation of a 
molecule.
107
 Oxygen is an excellent photo quencher; therefore, the molecules excited relaxation 
energy is transferred to neighboring molecular oxygen creating singlet oxygen. This form of 
oxygen has been found to be cytotoxic as it is an intermediate in the oxidation of biomolecules 
(e.g. DNA, proteins, and lipids).
108-109
 
1.3.5 Rare Earth Metals and Ionic Liquids 
Lanthanides have been easily dissolved into ionic liquids which can be attributed to the 
ether or hydroxyl functional groups on the alkyl chain on a cation.
110
 However, lanthanide 
compounds as an ionic liquid become immiscible in water at room temperature. Trivalent 
lanthanide beta-diketone complexes dissolved in ionic liquids (i.e. [1-hexyl-3-
methylimidazolium] [bis(trifluoromethylsulfonyl)imide], were found to have higher quantum 
yield and more photostability than if dissolved in an organic solvents (i.e. acetonitrile).
111-112
 
 Ionic liquids have been used as a solvent for the separation of lanthanide ions by a liquid-
liquid phase extraction method.
113-115
 Hydrophobic ionic liquids were used to separate 
lanthanides (i.e. europium, neodymium, and lanthanum) from aqueous solutions. The process 
was performed by adding the mixture of [1-alkyl-2-
methylimidazolium][bis((trifluoromethyl)sulfonyl)imide] ([Cnmim][Tf2N]) and 2-
thenoyltrifluoroacetone (tta) to the trivalent lanthanide hydrated complexes (Ln(H2O)n
3+
). The 
water molecules were removed from the inner coordination sphere due to the presence of the 
imidazolium cation and anionic exchange pathway from the ionic liquid (Scheme 1.4). 
Scheme 1.4. Liquid-liquid extraction using an ionic liquid and β-diketone were used to separate 
a lanthanide from a hydrate complex.
113
 
 
Ln(H2O)n
3+
 + 4Htta + [Cnmim][Tf2N] ↔ [Cnmim][Ln(tta)4] + 4H
+
 + Tf2N
-
 + nH2O 
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Ionic liquids within a silica network of ionogels have been doped with a trivalent 
lanthanide β-diketone complex resulting in the gel emitting luminescence upon ultraviolet 
irradiation.
116
 Ionogels consisting of a porous silica matrix and ionic liquid residing in the pores 
did not affect the luminescence intensity. 
 Ionic liquids have also been used as the priority solvent in a microwave nanoparticle 
synthesis. Lanthanide complexes dissolved in the ionic liquid were subjected to five minutes of 
microwave irradiation (ibid.) resulting in a lanthanide nanoparticle diameter of 15 nm. 
1.4 Hyperthermia as a Therapeutic 
1.4.1 Hyperthermal Therapeutics in Antiquity 
Over the millennia, dating back to Greek antiquity mankind has used barbaric forms of 
photodynamic therapy by ways of heat production
117
 and light
107
 to cure their ailments. Early 
civilizations would use heat via hot pokers to cauterize surface tumors or induced fevers to 
reduce ailments.
117-118
 In 500 BC, Parmenides introduced the idea of using fevers to cure saying, 
“Give me the power to produce a fever and I’ll cure all diseases.”119 Over a century (370 BC) 
later Hippocrates popularized the medical therapeutic using internal and external heat to treat 
diseases saying, “diseases that medicines do not cure are cured by the knife. Those the knife does 
not cure are cured by fire. Those that fire does not cure, must be considered incurable.”117 This 
use of fire led to more ‘sophisticated’ forms of hyperthermal methods using selective pokers 
(Figure 1.17).
118
 Hyperthermal methods were primarily performed by externally heating up a 
device to interact with the location of interest. This approach was not limited to heating up metal 
pokers, but also in the 1800-1900s electrically heated cautery probes were used. John Byrne 
devised an effective method on reducing tumors (i.e. uterine) with little chance of recurrence by 
creating a set of electrocautery tools.
120
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Figure 1.17. The harsh methods of hyperthermal treatment by use of (A) pokers and (B) 
electrocautery treatments were primarily used 400 BC – 1800 AD and 1800-1900 AD, 
respectively. (Obtained from references 
118
 and 
120
, respectively.) 
 
1.4.2 Induced Fever as a Cancer Hyperthermal Therapeutic 
 A fever is part of the systemic inflammatory response when the body creates a hostile 
environment for bacteria. The hostile environment includes an increase in white blood cells, 
increased heart rate, and a raise in core body temperature.
121
 Fevers can also be caused by the 
protein interleukin-1 in pyrogens.
122
 This type of therapeutic was observed in Hippocrates 
time,
123
 but seemed largely ignored by physicians until 1866.
124
 A German physician, Wilhelm 
Busch, was routinely checking on a patient that had a facial tumor and abruptly contracted an 
erysipelas (Streptococcus) infection. A symptom of erysipelas is a raise in body temperature due 
to the fever. The patient’s fever was very high and carried on for several days resulting in a 
decrease in the tumor mass.
124
 This medical record since then provided patients with an 
alternative method to cauterization for the removal of tumors and cure from other ailments (e.g. 
small pox, malaria, and typhoid) by having self-induced fevers.
125
 These slight rises in body 
A B
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temperature were sufficient to destroy tumor cells as supported by Byrne in 1889. Byrne 
determined that malignant cells would die at temperatures greater than 42°C.
126
 In the 20
th
 
century great progress towards alternative hyperthermal therapeutic methods were researched. 
Chemists began to formulate drugs that would cause the body to create fever-like symptoms 
without jeopardizing the patients overall health with injecting strains of bacteria.
127
 In 1933 a 
chemical compound originally designed for weight-loss, DNP (or 2,4-dinitrophenol) was able to 
raise the body temperature by increasing the metabolic rate.
128-129
 An increase in metabolic rate 
was due to DNP easily penetrating through the cellular lipid bilayers as a protonophore and 
reducing efficiency of the chemical energy, ATP (adenosine triphosphate).
130-132
 
1.4.3 Early Hyperthermal Therapeutics 
 
Figure 1.18. Wavelengths (in nanometers) become longer and lesser energetic from left-to-right 
in the electromagnetic spectrum. (Note: Not to scale.) 
 
 Light radiation therapy uses heat generated from emission energy; unfortunately, the 
exposure of higher energy wavelengths can lead to more serious side effects. Throughout the 
1940s – 1980s various light radiation therapies in concert with other drugs were being tested 
using different radiative sources (i.e. gamma rays from radon or cobalt-60). More presently, in 
the beginning of the 21
st
 century a more selective hyperthermal (or “radiothermal”) therapeutic 
device was put into the medical practice by introducing the trademarked name, Cyberknife.
133-134
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The Cyberknife system has operated to emit 45-70 Gy
e
 of X-ray irradiation to selectively treat 
malignant tumors.
135-136
 Research for irradiation therapy has shifted to the near-infrared spectrum 
with the invention of the laser (vide infra) (Figure 1.18). 
1.4.4 Infrared Spectrum 
 
Figure 1.19. The apparatus used by Herschel in 1800 was designed to measure radiant heat from 
refrangible invisible rays immediately beyond the prismatic spectrum. (A) and (B) are the stands 
used to hold the three thermometers, (C) and (D) are the prism, and (E) is the visible spectrum. 
Obtained from reference 
137
. 
 
 Academic research has been making strong grounds using lesser energetic and tissue 
absorbent wavelengths to treat malignant tumors.
138-139
 The wavelength of use is attributed to Sir 
Frederick William Herschel, and his notable discovery of infrared light and observation of 
radiant heat (λ ≈ 740 nm – 1 mm).137 Herschel discovered infrared light by obtaining a chromatic 
spectrum from prisms produced by the sun and placing thermometers next to both “vanishing 
                                                          
e
 A Gray (Gy) is the SI (Système International d'unités) unit of absorbed radiation energy from gamma ray or X-ray. 
1 Gy = 1 J · kg
-1
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rays,” violet and red (Figure 1.19). The radiant heat absorbed by the refracted invisible violet and 
red rays respectively resulted in 0.5-1 °C and 8-9 °C temperature increases. Herschel proposed 
calling these invisible rays that were “not fit for vision [yet] still exerting increasing energy,” the 
thermometrical spectrum. 
1.4.5 Light Amplification by Stimulated Emission Radiation 
1.4.5.1 Brief Background on LASER Origins 
Research has dramatically progressed since the observation of radiant heat from the 
“thermometrical spectral” infrared wavelength. Combining the previous statements on 
eradicating tumors conclude the necessity for artificially-produced infrared light emission of 
scientific purposes. The theoretical notion for light amplification by stimulated emission was 
from Albert Einstein’s 1917 article, Zur Quantentheorie der Strahlung (On the Quantum Theory 
of Radiation).
140
 Einstein’s paper along with other subsequent physicists (Ladenburg,141 
Fabrikant,
142
 Lamb and Retherford,
143
 and Kastler
144
) formulated the necessary ground work 
towards Charles H. Townes development of such an instrument (Figure 1.20).
145
 
 
Figure 1.20. Schematic of Townes’ microwave amplification by stimulated emission radiation 
instrument was originally developed to be a high-resolution microwave spectrometer. Obtained 
from reference 
145
. 
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1.4.5.2 LASER Components 
 In 1954 the principal investigator, Townes, developed the first device to amplify 
stimulated emission of microwave radiation. The microwave amplification by stimulated 
emission radiation (MASER) is comprised of three components to maintain high frequency 
emissions: gain medium, pump source, and focusing resonant cavity.
146-147
 Similarly to 
MASERs, light amplification by stimulated emission radiation instruments (LASER or laser) has 
employed solid-state materials, liquid solutions, or gas mixtures as a gain medium since its 
inception in 1960.
148
 Gain media are used excite the electronic energy levels and feasibility to 
stimulate a population inversion within the pumping source. Population inversion is when 
probability of molecules to be in excited state is greater than ground state. Stimulated emission 
of radiation is amplified by a series of cavity mirrors within the gain medium. In the focusing 
cavity component, all but one of the mirrors (i.e. resonant mirror) is 100% reflective allowing for 
release of high-intensity radiation output. Gain media that lasers have used to generating high-
intensity radiation have ranged from noble and inert gases, transition metal vapors, transition 
metal complexes, and lanthanide-doped metal complexes (Table 1.3). 
Table 1.3. Variable gain media towards the production of high-intensity output results in 
different wavelengths of radiation emission. Adapted from reference 
146
. 
 
 
Type Gain Medium Wavelength (nm)
Gas He(g), Ne(g) 3391, 1151, 632, 544
Gas N2 (g) 337
Gas Ar+(g) 488, 515
Gas K+(g) 647
Gas CO2(g) 10,000
Gas Cu(g) 510
Gas He(g), Cd(g) 441, 325
Solid-State Cr3+:Al2O3 694
Solid-State Nd3+:Y3Al5O15 1064
Solid-State Nd3+:Y3LixFy 1054
Solid-State Ti3+:Al2O3 780
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1.4.6 Laser Hyperthermal Cancer Therapeutics Techniques 
1.4.6.1 Laser Photothermal Origins 
Presently, hyperthermal techniques to destroy cancerous tumors use nanomaterials 
activated by a near-infrared Nd
3+
:Y3Al5O15 (Nd:YAG) laser. These studies employ 
nanomaterials to absorb the near-infrared (NIR) lasing wavelength to result in thermal emissions. 
John F. Ready and T. J. Harris determined photothermal effects from laser irradiation absorption 
in 1963.
149-151
 The material (i.e. Al, Fe, Cu, W, and Pt) used to absorb the laser emissions had an 
immediate rise (i.e. 1 ns) in temperature that resulted in vaporization. The metals under laser 
power density of 5 TW·cm
-2
 at 10 ns pulses (0.2 mm diameter focal spot) experienced 
temperature increases of 500 °C before an observed “plume of vaporized material.”151 Since then 
hyperthermal therapeutics has increasingly become a popular approach on treating cancerous 
tumors opposed to cautery or induced-fever techniques (Figure 1.21). 
 
Figure 1.21. Hyperthermal therapeutics became more popular since the invention of the MASER 
in 1954.
f
 
 
A team of physicians led by Paul McGuff used a solid-state ruby (Cr
3+
:Al2O3) laser to 
destroy 20 different types of cancer cells in 1964.
152
 Unlike Ready and Harris, McGuff used 
                                                          
f
 Histogram was derived from article frequency searching the following key phrases in the "Web of Knowledge" 
database: Hyperthermia (hypertherm- and phototherm-), and Laser Hyperthermia (hypertherm- or phototherm-, and 
laser or maser). 
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relatively lower power density of 4 MW·cm
-2
 at 3 ms pulses to eradicate the malignant tumors. 
The cancerous tumors were destroyed with a lasing focal spot diameter of 2 mm ultimately 
resulting in a temperature increase (distance from lasing area): 380 °C (2 mm), 94 °C (5 mm), 
and 46 °C (10 mm). Cancer cells are more prone to heat due to poorer vascularization than 
healthy cells.
153
 This method proved to be successful and less invasive than previous 
hyperthermal therapeutics such as gamma irradiation and cautery techniques.
152, 154-158
 Although 
there seemed to be excitement for hyperthermal cancer therapeutics, research efforts using laser 
technology only progressed 35 years after McGuff’s publication. 
1.4.6.2 Near-Infrared Transparency of Human Tissue 
 
Figure 1.22. The optical penetration depth (mm) of human skin is highest in the near infrared 
region. Obtained from reference 
138
. 
 
From 1964 to 1999 there were about 600 publications on hyperthermal techniques 
towards cancer therapy, but that number has more than doubled since the millennia with 1,400 
publications. Most of these publications use lasers that emit infrared irradiation for the purpose 
of reaching a malignant tumor percutaneously. Human tissue (i.e. skin) weakly absorbs infrared 
wavelengths allowing infrared laser irradiation to penetrate without a prior incision or resection 
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(Figure 1.22).
138
 Therefore, infrared irradiation has been absorbed by various nanomaterials 
towards a hyperthermal cancer therapeutic. 
1.4.7  Nanomaterials Used as a Hyperthermal Therapeutic 
 Nanomaterials (e.g. particles, rods, shells, etc.) that have been researched to produce 
hyperthermia upon near-infrared laser irradiation include the following: Au,
139
 CuS,
159
 carbon 
nanotubes,
160
 and porphysomes.
161
 The hyperthermal nanomaterials use surface plasmon 
resonance (sans carbon nanotubes) and absorbance to generate thermal effects. Variable infrared 
laser irradiation wavelengths were used (e.g. 660, 760, 820, 980, and 1064 nm) based upon the 
nanomaterials absorbance maxima. These materials have generated above the 42 °C threshold for 
hyperthermia.
153, 162
 The hyperthermal effects (e.g. cellular apoptosis or necrosis) using 
nanomaterials were demonstrated with in vitro and in vivo models (Figure 1.23). Cellular 
apoptosis death is when a cell is triggered to complete a final metabolic process before dying, 
while necrosis is immediate death. 
 
Figure 1.23. Nanomaterials studied in vitro
163
 and in vivo
160
 were used in concert with infrared 
laser irradiation hyperthermia as a cancer therapeutic. (A) Nanomaterial control, (B) saline 
control, (C) laser control, and (D) nanomaterials and laser. Obtained from references 
163
 and 
160
 
respectively. 
 
A B C D
A B
DC
In vivoIn vitro
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1.4.7.1 Hyperthermal Cancer Therapeutic Using Gold Nanomaterials  
Gold nanomaterials for the purpose of hyperthermal cancer research have existed in many 
shapes such as particles (spheres), rods, and shells. Regardless of the shape, the gold 
nanomaterials tend to have to have an absorbance maximum around 820 nm.
139
 A NIR laser at 
820 nm is used for optimal photothermal heating since that is the absorbance maximum. Gold 
nanomaterials (150 – 300 µg mL-1) were capable of generating an increase of 40 – 60 °C heat 
upon laser irradiation. The generated heat was proven successful in the destruction of cancerous 
cells as depicted in figure 1.21. 
1.4.7.2 Hyperthermal Cancer Therapeutic Using Carbon Nanotubes 
Carbon nanotubes (~400 nm) were also capable of achieving a laser generated heat 
increase of 40 – 60 °C at concentrations 5 – 30 µg mL-1.25, 160 The laser wavelength used for 
carbon nanotubes was at 980 or 1064 nm. The carbon nanotubes were synthesized to become 
more biocompatible such as encasing (held by π-π stacking) with DNA, or conjugating folate to 
the carboxylic sites. 
1.4.8 Magnetic Hyperthermal Method 
Magnetic hyperthermia is cancer therapeutic that does not use NIR laser to produce heat, 
but instead by a magnetic field. Magnetic hyperthermia functions by the alternating magnetic 
field (230 kHz) on the compound. The magnetic moment of a compound is proportional to the 
amount heat generated.
164
 Nanoparticles that have demonstrated magnetic hyperthermia are iron-
based (e.g. iron oxides and iron cobalt). The magnetic nanoparticles were capable of producing 
20 – 35 °C heat using 10 mg mL-1.165 Cancer cells under the influence of magnetic nanoparticles 
and an alternating field were 70% destroyed. 
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1.5 Scope of Dissertation 
The objective of the research was to study the spectroscopic properties of nanoGUMBOS 
using a lanthanide (i.e. europium) or near infrared dyes (i.e. 1048 and 1061). Herein this 
dissertation a comparative discussion on the bulk and nanoparticle luminescence of lanthanide-
based nanoGUMBOS is detailed. In addition, an alternate hyperthermal technique using 
nanomaterials based on GUMBOS will be discussed. The nanoGUMBOS will use an infrared 
cationic dye and biocompatible anions to be used as a cancer therapeutic. 
In Chapter 2, lanthanide-based nanoGUMBOS were produced by an aerosol method 
resulting in particle sizes of 39.5 ± 8.4 nm. An intense luminescence peak at 613 nm from 
europium (III) was prevalent when bulk lanthanide-GUMBOS, [C6mim][Eu(tta)4], was dissolved 
in ethanol. Contrastingly, luminescence from the lanthanide nanoGUMBOS was less intense at 
613 nm and fluorescence from the imidazolium cation was prominent at 420 nm. It is concluded 
that the cation surrounds the anion negatively affecting europium luminescence intensity. 
In Chapter 3, NIR nanoGUMBOS were synthesized in various pH media (2, 5, 7, 9, and 
11) by a reprecipitation method using an ultrasonic probe sonicator. The nanoGUMBOS varied 
in sizes, aggregation, and structural makeup due to the different pH. A photothermal study of the 
NIR nanoGUMBOS was conducted. The aqueous suspended NIR nanoGUMBOS released a 
thermal energy increase of 13 – 23 °C when irradiated for five minutes by a 1064 nm NIR 
(Nd:YVO4) laser. Photothermal efficiency was calculated to range from 13 – 64% and inversely 
correlated with the band gap energies from the NIR nanoGUMBOS, [1048][Ascorbate], 
[1061][Ascorbate], [1048][Deoxycholate], and [1061][Deoxycholate]. 
In Chapter 4, NIR nanoGUMBOS synthesized from a microwave-assisted reprecipitation 
method was used for a hyperthermal therapeutic on MDA-MB-231 breast cancer cells. The NIR 
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nanoGUMBOS employ a [Folate] anion for targeting the overexpressed folate-receptor alpha 
proteins that jacket cancer cells. The NIR nanoGUMBOS, [1048][Folate] and [1061][Folate], 
had limited cytotoxicity sans 1064 nm NIR (Nd:YVO4) laser irradiation. However, the 
photothermal energy emitted by the NIR nanoGUMBOS during irradiation in cell media 
increased 25 – 35 °C. The NIR irradiation and NIR nanoGUMBOS in concert successfully 
destroyed breast cancer cells after 20 minutes of continuous irradiation. 
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Chapter 2. Lanthanide-Based Luminescent NanoGUMBOS
*
 
2.1 Introduction 
 The transfer of excitation energy directly to the lanthanide metal results in relaxation 
through photon emission. Therefore, trivalent lanthanide (Ln) luminescence requires energy 
transfer from a donor molecule because of shielded 4f valence subshells as a result of higher 
outlying subshells (5s
2
 and 5p
6
) from the Xe core.
1-2
 The process of lanthanide luminescence is 
enabled when a donor (i.e. ligand) absorbs a photon followed by transfer of energy through 
processes of nonradiative relaxations (e.g. intersystem crossing, intra-ligand charge transfer, or 
ligand-to-metal charge transfer). Common characteristics of lanthanide emission are intense-
narrow peaks, with relatively long lifetimes, and good photostability due to shielded 4f-orbital. 
Owing to these distinctive luminescence properties, lanthanides have found many interesting 
analytical applications.
3-5
 Recently, several studies reporting some of the unique spectral 
properties of lanthanides have also been reported. For example, near infrared emission,
6
 
upconversion capabilities,
7-8
 and biological therapeutic applications
9-10
 have made them 
attractive alternatives to organic fluorophores, quantum dots, and laser materials.
11
 
Covalently binding or encapsulating lanthanides in nanoparticles have also been reported 
to yield fluorescent and paramagnetic nanoparticles.
10, 12-13
 The most commonly used nanocarrier 
of lanthanide containing species is silica. In a recent report, lanthanide-containing silica 
nanoparticles have been prepared by coordinating lanthanides to polymers, such as 
terephthalates, for integrated optics and electroluminescent materials, and doped as antennas for 
biolabels in immunoassays.
8-9, 14-16
 Lanthanide-containing nanoparticles have been found to 
maintain their characteristic emission lines relative to Ln (III) ions dissolved in solution.
17-20
  
                                                 
*
 Reprinted (adapted) with permission from Dumke, J. C.; El-Zahab, B.; Challa, S.; Das, S.; Chandler, L.; Tolocka, 
M.; Hayes, D. J.; Warner, I. M. Lanthanide-Based Luminescent NanoGUMBOS. Langmuir 2010, 26 (19), 15599-
15603. Copyright 2012, American Chemical Society. 
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Lanthanides coordinated with ionic liquids have also been reported.
21
 Combining ionic 
liquids with lanthanides allows for a concerted use of the favorable photoproperties of the rare 
earths and exploitation of the tunability of ionic liquids.
22
  Ionic liquids have also been used as 
alternative solvents in synthesis and catalysis to replace conventional organic solvents.
23
 By 
definition, ionic liquids consist solely of cations and anions and have melting points at 100 ºC or 
below.
24
 Since many higher melting salts are of interest to our research group and do not fit this 
general definition (25 – 250 ºC), we have recently coined the term Group of Uniform Materials 
Based on Organic Salts (GUMBOS) for our studies.
25
 
Herein, we report on the preparation, characterization, and studies of the spectral 
properties of lanthanide containing nanoGUMBOS. The possibility of tuning the properties of 
GUMBOS by exchanging the cation or anion allows for a wide range of potential applications 
that extend into photochemical catalysis, sensory devices, photovoltaics, and many analytical 
applications.
24-27
 
2.2 Synthesis and Characterization of Europium (III) GUMBOS and NanoGUMBOS 
2.2.1 Synthesis and Characterization of Europium (III) GUMBOS 
The following synthetic procedure was modified from Nockemann, et al.: 1.5 mmol 1-
hexyl-3-methylimidazolium chloride ([C6mim][Cl]), 6 mmol 2-thenoyltrifluoroacetone (tta) β-
diketone, and 6 mmol of 1.0 M aqueous sodium hydroxide (NaOH) were mixed simultaneously, 
followed by addition of spectroscopic-grade ethanol (Scheme 2.1).
28
 The mixture was vortexed 
until the material was fully dissolved at room temperature. An aqueous solution of 0.1 M of 
europium (III) chloride hexahydrate was added to the sample at 50 °C under agitation for 90 
minutes. The sample was allowed to cool to room temperature overnight. The decantant was 
removed and the remaining precipitate was washed and filtered using a Büchner funnel with 
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chilled triply-distilled water. The solid was lyophilized for 30 hours to remove excess water. The 
final [C6mim][Eu(tta)4] product was a yellow powder and was stored in the dark at room 
temperature. A DSC q100 Differential Scanning Calorimeter instrument was used to measure the 
melting point of the solid bulk GUMBOS, 121.33 °C (Figure 2.1) 
Scheme 2.1 Reaction scheme of the formation of [C6mim][Eu(tta)4]. 
 
 
Figure 2.1 Differential scanning calorimetry melting point of the GUMBOS, [C6mim][Eu(tta)4]. 
 Elemental analysis supports the complete formation of the GUMBOS opposed to the 
materials existing independently (Table 2.1). Chelation of the β-diketone to the europium (III) 
metal can be qualitatively confirmed by exciting the material with a long-wave UV lamp. The 
europium (III) will not emit luminescence unless a donor molecule is chelated and transfers 
energy to the lower-lying f-orbitals. 
+
(1) NaOH (aq)
Ethanol
(2) EuCl3 • 6H2O
50 °C
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Table 2.1  Elemental analysis (CHNOFS-results) of the dry GUMBOS including the theoretical 
element percentage of the elements with the β-diketonate chelated to the europium (III) (i.e. 
GUMBOS and nanoGUMBOS) and if there was not chelation. The percent difference supports 
that the β-diketone chelates to the europium (III). 
 
Elemental Analysis 
Element 
Experimental
% 
 
Theor.% 
%Diff. 
 
Theor.% 
%Diff. 
C 41.24 41.90 1.6 41.76 1.2 
H 2.78 2.93 5.1 3.25 14.5 
N 2.36 2.33 1.3 2.32 1.7 
O 11.15 10.63 4.9 10.60 5.2 
F 19.21 18.94 1.4 18.87 1.8 
S 10.29 10.65 3.4 10.62 3.1 
 
2.2.2 Synthesis and Characterization of Europium (III) NanoGUMBOS 
 
A 0.24 mM [C6mim][Eu(tta)4] solution in acetonitrile was prepared and then pressure 
nebulized at 32 psi to generate aerosol. The aerosol was then carried through a silica drier to 
remove humidity, followed by passage through a 400 °C tube furnace to evaporate the solvent. 
The dry particles were then collected on a 0.45 μm PTFE membrane filter (Whatman Gmbh) and 
then resuspended in distilled water through bath sonication. To characterize the particles, 2 µL of 
the suspension were drop cast on a 400 mesh ultrathin carbon-film copper grid. Transmission 
+
(1) NaOH (aq)
Ethanol
(2) EuCl3 • 6H2O
50 °C
+
(1) NaOH (aq)
Ethanol
(2) EuCl3 • 6H2O
50 °C
+
(1) NaOH (aq)
Ethanol
(2) EuCl3 • 6H2O
50 °C
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electron microscope (TEM) images from a Delong LVEM5 instrument showed relatively 
uniform and near-spherical particles with an average particle size of 39.5 ± 8.4 nm (Figure 2.2). 
 
Figure 2.2 TEM image of [C6mim][Eu(tta)4] nanoGUMBOS preparated using the aerosolization 
process. The particles had an average diameter of 39.5 ± 8.4 nm.  
 
 
Figure 2.3 XPS spectra of the [C6mim][Eu(tta)4] dry GUMBOS (gray) and dry nanoGUMBOS 
(black). 
 
Confirmation of the molecular composition of the nanoGUMBOS was performed using a 
Kratos Axis 165 X-ray photoelectron spectroscopy (XPS) with an Al Kα (1486.6 eV) anode. XPS 
provides information on inner-shell electrons at the valence levels in order to determine the 
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electronic states and composition of the unknown material.
29
 As shown in Figure 2.3, the XPS 
spectrum of the dry GUMBOS was nearly identical when compared to the dry nanoGUMBOS. 
Nevertheless, the overall intensity increased and the binding energy of europium’s 3d level 
increased in intensity, suggesting more exposure of europium’s valence shell in the 
nanoGUMBOS than in the bulk GUMBOS.
29
  
2.3 Spectral Properties of Europium (III) GUMBOS and NanoGUMBOS 
2.3.1 Calculation of Förster Resonance Energy Transfer (FRET) Parameters  
The spectral overlap integrals for donor ([C6mim]):acceptor (europium (III)) was calculated 
using the formula
2
 
                  
 
 
    Equation 2.1 
where, J(λ) is the overlap integral, ε is the extinction coefficient of the of the acceptor,   is the 
normalized emission spectrum of the donor and λ is the wavelength. In this manuscript,  the 
overlap integrals are also expressed as percentages of the maximum value possible.
30
 The energy 
transfer efficiencies are calculated using the formula 
    
   
  
     Equation 2.2 
where, FDA  and FD are the integrated fluorescence intensity of the donor in the presence and 
absence of acceptor, respectively.
31
 The J(λ) and E values in Table 2.2 were calculated from the 
observed energy transfer from the [C6mim] to the europium (III) in aqueous and ethanol 
solutions when excited at 340 nm with slit widths at 5 nm. A concentration of 0.5 M [C6mim] 
and 0.5 M europium (III) was compared to show that the pure 0.5 M [C6mim] has higher 
emission intensity than when 0.5 M europium (III) is in the solution (Figure 2.4). In addition, the 
emission intensity for europium (III) is higher with [C6mim] than without, supporting that the 
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imidazolium is contributing energy transfer to the lanthanide. The energy transfer was more 
efficient in an organic solvent than aqueous due to the polarity differences of the compounds.
32
  
 
Figure 2.4 Energy transfer was observed from the [C6mim] to the europium (III) in aqueous (A) 
and ethanol (B) solutions. Concentrations of pure 0.5 M [C6mim] (dotted line) and pure 0.5 M 
europium (III) (dashed line) were compared to show that the mixture (bold line) had higher 
europium (III) emission intensity. 
 
Table 2.2 The overlap integral (J) and energy transfer efficiency (E) from donor (C6mim
+
) to 
acceptor (Eu
3+
) in a 1:1 ratio. 
 
Material (solvent) J (cm
6
mol
-1
) E 
1) GUMBOS (ethanol) 
 
2) NanoGUMBOS (water) 
 
3.96×10
-15 
 
2.36×10
-16 
65.7% 
 
7.48% 
360 460 560 660λ (nm)
360 460 560 660λ (nm)
(B)
(A)
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2.4 Spectral Properties of the GUMBOS, [C6mim][Eu(tta)4] and Derived Nanoparticles 
2.4.1 Absorbance Measurements of GUMBOS and NanoGUMBOS 
Absorbance properties were studied for the bulk GUMBOS dissolved in ethanol, while 
the nanoGUMBOS studied involved suspensions in deionized water (18.2 MΩ). All absorbance 
measurements were performed in 1 cm path length quartz cuvette, with a scan rate of 0.17 nm s
-1
 
at 1 nm slit width using a Shimadzu UV-3101PC UV-Vis-NIR scanning spectrophotometer. Due 
to low molar absorptivity of the europium (III) (Figure 2.5), the absorption spectrum of the 
GUMBOS was predominately from the β-diketonate complex. A broader absorbance peak was 
observed for the nanoGUMBOS suspension as compared to the dissolved GUMBOS (Figure 
2.6). Another observed absorbance shoulder of nanoGUMBOS was a slight emerging peak at 
290 nm. This peak is due to the imidazolium cation and the minute impurities from the starting 
material.
33
 This emergence of [C6mim] cation absorbance peak indicates that the imidazolium 
plays an important role within the morphology of the nanoGUMBOS. This role is further 
explored in the subsequent sections. 
 
Figure 2.5 Absorption of 0.1 M EuCl3 dissolved in water. 
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Figure 2.6 Absorbance spectra of the aqueous suspension of nanoGUMBOS (solid line) and a 
0.8 µM ethanol solution of GUMBOS (dashed line). 
 
2.4.2 Luminescence Measurements of GUMBOS and NanoGUMBOS 
Luminescence measurements were performed on both the nanoparticle aqueous 
suspension and bulk material dissolved in ethanol using orthogonal instrument geometry and a 1 
cm path length quartz cuvette. The GUMBOS and nanoGUMBOS emission intensities were 
monitored with the excitation and emission slit widths set to 5 nm using a SPEX Fluorolog-3 
Jobin Yvon spectrophotometer. An excitation-emission matrix (EEM) was collected and a 
contour luminescence map was plotted for both the dissolved GUMBOS and the suspended 
nanoparticles (Figure 2.7). The EEM contour maps were collected by exciting the samples using 
previously mentioned slit widths at every 5 nm and emission was collected in 2.5 nm increments. 
Single emission spectra were collected by exciting at every 1 nm and recording emission at every 
nanometer. This luminescence is associated with europium’s most intense transition (5D0 → 
7
F2) 
at 613 nm when excited at the complexes’ excitation apex of 340 nm. The most immediately 
observed difference in the nanoGUMBOS emission spectrum was the appearance of a broad 
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peak at 420 nm. This emission phenomenon was visible in the nanoparticle suspension and also 
when [C6mim][Eu(tta)4] was dissolved in [C6mim][Tf2N] as explained later (Figure 2.8). In 
contrast, [C6mim][Eu(tta)4] dissolved in ethanol and other organic solvents did not have a 
noticeable emission peak at 420 nm. The europium (III) characteristic emission peaks at 596 (
5
D0 
→ 7F1) and 613 nm (
5
D0 → 
7
F2) were however presented in all dissolved and particle suspension 
samples. 
 
Figure 2.7 (A) Excitation-Emission Matrix (EEM) of (A) 0.8 µM GUMBOS dissolved in 
ethanol and (B) nanoGUMBOS suspension in water. Emissions between 250-400 nm and 500-
650 are due to second-order scattering. 
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2.4.2.1 Imidazolium Fluorescence Influence 
Further studies were performed to characterize the emission profile of the 
nanoGUMBOS, including the intense fluorescence spectral phenomenon observed at 420 nm and 
the europium (III) emission peaks. The emission peak at 420 nm could be thought to originate 
from uncommon luminescence of europium (III) at the 
5
D3 → 
7
F1 transition, light scattering from 
the particles, or the spin-favored 5d-4f transition of europium (II).
1, 34-35
 However, since ionic 
liquids are not generally known to be reducing solvents and the energy required for the 5d-4f 
transition of europium (II) is greater,
16
 it was concluded and supported by XPS analysis that 
europium (III) was the predominant species in all samples (Figure 2.3). Therefore, the emission 
at 420 nm was found to result from fluorescence of the cationic species, [C6mim].
36
 Thus, the 
excitation of the nanoGUMBOS accentuates emission from europium (III) and imidazolium 
cation (Figure 2.8). It can be further supported from Figure 2.8B that the broad 420 nm emission 
derives from the imidazolium cation. Figure 2.8C is a depiction of the GUMBOS dissolved in an 
ionic liquid that has the identical cation species. The overexpression of imidazolium emerges in 
the emission spectrum unlike in Figure 2.8A which has a 1:1 mole ratio of imidazolium to 
europium (III). 
Dissolution of the GUMBOS (0.8 µM) into liquid [C6mim][Tf2N] also produced the 
imidazolium 420 nm emission peak in addition to europium (III) luminescence at 613 nm as is 
shown in Figure 2.8C. The normalized imidazole and europium (III) luminescence peaks reveal 
close overlap with the previously described emission profiles (Figure 2.9).
37
 The nanoGUMBOS 
having an abnormal reduction in lanthanide emission and increased imidazolium fluorescence 
suggests a quenching behavior.
38-39
 This behavior can be explained through the formation of an 
organization of imidazolium cations surrounding the lanthanide anion, as suggested by 
61 
 
Chaumont et al.
40-41
 The proposed reasoning of an assembly of imidazoles surrounding the anion 
would overwhelmingly quench the luminescence released by europium (III) as supported by the 
emission spectrum of nanoGUMBOS. The dissolved GUMBOS in ethanol lack the formation of 
such a quenching opportunity as ions are randomly flowing in solution; thereby, the europium 
(III) luminescence quenches the [C6mim] fluorescence via collisions. As shown with the ionic 
liquid solvent in Figure 2.8C, the addition of excess [C6mim] enhances the 420 nm fluorescence. 
 
Figure 2.8 Excitation (340 nm, dashed line) and emission (613 nm, solid line) spectra of 
GUMBOS and nanoGUMBOS. (A) 0.8 µM GUMBOS dissolved in ethanol, (B) nanoGUMBOS 
suspension in water, and (C) 0.8 µM GUMBOS dissolved in liquid [C6mim][Tf2N]. 
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Figure 2.9 Normalized emission spectra of GUMBOS dissolved in ethanol (solid) and 
[C6mim][Tf2N] (dash), and nanoGUMBOS in water (dot) while focusing on the emissions 
directly from (A) [C6mim] and (B) europium (III) when excited at 340 nm. (Note: The ethanol 
Raman peaks were removed for clarity.) 
 
2.4.2.2 Förster Resonance Energy Transfer 
The enhanced luminescence of europium (III) in the GUMBOS and nanoGUMBOS is 
attributed to ligand-to-metal charge transfer from the β-diketone and FRET from the [C6mim] to 
europium (III)
 
complex.
36, 42
 FRET can be examined by monitoring the emission of the 
GUMBOS and the nanoGUMBOS in the presence and absence of energy transfer. Since 
[C6mim] has considerable absorbance at 340 nm, while the absorbance of europium (III) is 
negligible at this wavelength, it can be suggested that excitation of the GUMBOS and 
nanoGUMBOS at 340 nm will selectively excite the [C6mim]. However, exciting at 395 nm will 
selectively excite the europium (III) since this is its absorption maxima, but an absorption 
mimima for [C6mim]. Hence, it can be considered that excitation of the GUMBOS and the 
350 450 550 650l (nm)
350 450 550 650l (nm)
(B)
(A)
63 
 
nanoGUMBOS at 340 nm will lead to energy transfer from [C6mim] to europium (III) and 
enhancement in europium (III) luminescence, which is weakly observed for excitation at 395 nm. 
Figure 2.10 shows the luminescence of the GUMBOS and nanoGUMBOS in the presence and 
absence of energy transfer. It was observed that the J(λ) and E values are much higher in organic 
solvent as compared to water (Table 2.2).
2
 
 
This supports our observation of approximately 66.8 
times enhancement in europium (III) luminescence intensity of the GUMBOS in ethanol as 
compared to 7.46 times enhancement in nanoGUMBOS suspended in water. Since β-diketone is 
nearly non-fluorescent in the studied solvents, FRET from β-diketone is considered to be 
negligible. The β-diketone participates in ligand-to-metal charge-transfer when enhancing 
europium (III) luminescence.
42
 
 
Figure 2.10 Energy transfer was observed from the [C6mim] to the europium (III) as dissolved 
GUMBOS in ethanol (A) and suspended nanoGUMBOS in water (B) when excited at the 
absorption maxima (340 nm, dashed line) and absorption minima (395 nm, bold line) with slit 
widths at 5 nm. 
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Differences in emission intensity observed between the dissolved species and suspended 
nanoparticles are a resulted from water as a static quencher. The oxygen atom in water forms a 
complex with the formally luminescent compound rendering the compound nonluminescent.
43-44
 
Figure 2.7 shows an EEM spectrum of the nanoGUMBOS, revealing a slight red shift of the 
europium electric dipole peak from 613 nm to 615 nm (
5
D0 → 
7
F2).  In contrast, the magnetic 
dipole emission peak intensity increased, with a solvatochromic shift from 596 nm to 591 nm.
45
 
The magnetic dipole transition of 
5
D0 → 
7
F1, gave an 8% relative difference in emission intensity 
from the electric dipole transition dipole peak as a nanoparticle. Likewise, the magnetic dipole 
peak exhibited a relative emission difference of 18% as compared to the electric dipole emission 
peak of the dissolved species. Due to molecular aggregation into solid state particles, the electric 
dipole emission intensity peak decreased in intensity from the dissolved GUMBOS because of its 
sensitivity to the environment.
36, 46
 The difference in intensities for the magnetic and electric 
dipole transitions explains the spectral characteristic sensitivity to the particles’ environment. 
2.4.2.3 Photostability and Lifetime Decay 
When dissolved in organic solvents, the β-diketonate ligand was not photostable, 
requiring the spectral studies to be conducted directly. Nockemann et al. reported that the 
chelated-ligand retained 80% of its photostability over 10 days of constant daylight after 
dissolution in acetonitrile.
28, 47
 The radiative lifetime decay times for the GUMBOS are relatively 
similar to other lanthanide luminescent lifetime decay times (micro- to millisecond timeframe) 
and have an exponential lifetime decay profile (Figure 2.11).
48
 These studies were performed 
using a Fluoromax 4 with a Time Correlated Single Photon Counter, and excited through a 
sample compartment adapter at 340 and 390 nm for a pulsed nanoLED (800 ps at a rate of 1 
MHz) for fast lifetimes (i.e. 430 nm) and spectralLED for long lifetimes (613 nm), respectively. 
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When dissolved in ethanol, the GUMBOS yielded slightly longer luminescent lifetime decay at 
the europium (III) emission (613 nm) relative to the nanoGUMBOS suspension in water (61.0 
and 47.7 µs, respectively). In addition, there was not a recordable fluorescent lifetime decay for 
the suggested imidazolium fluorescence (420 nm) when dissolved in ethanol. Imidazolium 
fluorescence has been found to have a relatively short lifetime, i.e. shorter than 800 ps.
49
 
However, the imidazolium in the nanoGUMBOS had a lifetime decay of 1.75 ns.  The changes 
in lifetime decay are directly proportional to the compounds relative emission intensities.  
 
Figure 2.11 Time-domain europium (III) emission decay time of aerosolized nanoparticles, 
[C6mim][Eu(tta)4], resuspended in water. 
 
In comparing of the dissolved GUMBOS and nanoGUMBOS emission spectra, it can be 
concluded in parallel that with the emergence of [C6mim] fluorescence, a detectable lifetime was 
recorded. In addition, europium (III) luminescence decreases relative to that of the counter ion 
emission, leading to a decrease in lifetime decay. The increase in lifetime for the imidazole in 
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nanoGUMBOS is believed to be due to a reduction of collisional quenching and multiphonon 
relaxation onto the more relaxed fluorophore.
50
 In contrast, the dissolved GUMBOS experience 
greater collisional quenching which supports the reasoning for a lower fluorescence obtained by 
the [C6mim] cation as a dissolved species. Thereby, the decrease in luminescence suggests an 
aggregation of imidazolium cations around the anion in the morphology of the nanoparticle. 
2.5 Conclusion 
The formation, uniformity, and optical properties of [C6mim][Eu(tta)4] nano/GUMBOS 
has been thoroughly investigated. The increased surface area of the 39.5 ± 8.4 nm 
nanoGUMBOS and outer arrangement of the imidazolium cation afforded photoluminescence 
from cationic and anionic components. The imidazolium fluorescence was observed to be more 
intense than the europium (III) luminescence in the nanostate supporting Chaumont et al. 
computational theory of cations surrounding an anion with a lanthanide center. The cation 
fluorescence was due to a molecular outer arrangement within the nanoGUMBOS when 
producing an emission peak at 420 nm. These nanoGUMBOS emerge as promising candidates 
for sensory, optical, and photovoltaic applications. 
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Chapter 3. Photothermal Response of Near-Infrared NanoGUMBOS 
3.1 Introduction 
Dual properties from a single material have been achieved with tunable ionic materials 
known as GUMBOS (Group of Uniform Materials Based on Organic Salts). These GUMBOS 
have been shown to afford concerted properties such as fluorescence and magnetism,
1
 chirality 
and magnetism,
2
 chirality and fluorescence.
3
  GUMBOS can also be specifically designed to 
achieve desired properties through a simple exchange of the appropriate counterions. In addition 
to tailoring GUMBOS with specific functional properties, other physical and chemical properties 
(e.g. viscosity, solubility, absorption and emission wavelengths, and melting point) can also be 
altered by careful selection of the constituent ions.
1
  
Nanoparticles derived from GUMBOS, coined nanoGUMBOS, have been successfully 
synthesized by employing various methods including melt-emulsion-quench,
4
 reverse-micelle,
1
 
reprecipitation,
5
 and aerosolization.
6
 Each of these methods has comparative advantages and 
limitations that include particle size range, particle monodispersity, and yield. Bulk GUMBOS 
often possess somewhat different spectral properties than the nanoscale equivalent 
(nanoGUMBOS).
6
 Previously, Bwambok et al., utilized a reprecipitation approach to synthesize 
near-infrared (NIR) nanoGUMBOS for biomedical imaging inside cells.
7
 
The NIR spectrum is of great interest for biomedical applications since the absorbance of 
skin tissue is low and the optical penetration depth is near maximum in this region.
8
 Therefore, 
various studies have been conducted to investigate NIR compounds as biomedical fluorescent 
probes,
9
 solid-state and dye lasers,
10
 and for thermal energy generation.
11
 Biomedical probes 
have been employed to visually locate an area of interest by producing fluorescence upon 
excitation.
12-14
 In addition to a radiative transition, they also produce non-radiative transitions 
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which release energy in the form of heat. Photo-responsive materials that produce heat have 
recently gained interest due to their clinical applications and promising activity in destroying 
cancer through hyperthermia.
15
 
Materials capable of converting photons efficiently to heat upon excitation by use of a 
near IR laser are of great interest for developing in vivo hyperthermic therapies.
16
 Light-
responsive organized media nanoparticles,
17
 functionalized nanotubes,
18
 gold nanoshells,
19
 or 
polymer nanogels
20
 are some of the nanomaterials previously utilized to achieve controlled cell 
destruction using hyperthermia. The aforementioned nanomaterials were photothermally 
activated using near infrared lasers in the range of 650 – 1064 nm. The organized media used in 
this study was developed from a porphysome supramolecular self-assembly which formed 100 
nm nanovesicles capable of reaching temperatures of up to 60 °C in tissue within a minute of 
irradiation at 658 nm.
17
 Since these nanovesicles are designed from phospholipid-porphyrin self-
assembled conjugates, they are considered to be biodegradable. Other nanomaterials used 
external agents to increase biocompatibility; for example, carbon nanotubes have been 
functionalized with DNA, and gold composite nanoparticles have been coated with polyethylene 
glycol.
18-19
 Gold nanomaterials have been observed to reach substantial photothermal 
temperatures of up to 60 °C in solution or tissue through decay of localized surface plasmon 
resonance modes.
11, 19
 Unfortunately, these nanomaterials often require extensive syntheses to 
improve biocompatibility for use in applications such as cancer therapy. 
Herein, we report a class of NIR nanoGUMBOS which were synthesized using a facile 
two step procedure with photothermal cations and biocompatibile anions
21-24
 resulting in a stable 
nanoformulation.
4
 Nanoparticles were derived from four NIR GUMBOS obtained using a 
combination of two cationic NIR dyes and two biocompatible anions and their physical, spectral, 
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and hyperthermal characteristics were investigated. Examination of the results suggests a 
possible use in cancer therapy. These studies also reveal altered morphological and photothermal 
characteristics in acidic, neutral, and basic environments which yield information regarding the 
true fate of the nanoparticles in the acidic environment of the tumors. 
3.2 Experimental 
3.2.1 Materials 
Sodium ascorbate, sodium deoxycholate, 1-Butyl-2-[2-[3-[(1-butyl-6-
chlorobenz[cd]indol-2(1H)-ylidene)ethylidene]-2-chloro-1-cyclohexen-1-yl]ethenyl]-6-
chlorobenz[cd]indolium tetrafluoroborate ([1048][BF4]) and 4-[2-[2-Chloro-3-[(2,6-diphenyl-
4H-thiopyran-4-ylidene)ethylidene]-1-cyclohexen-1-yl]ethenyl]-2,6-diphenylthiopyrylium 
tetrafluoroborate ([1061][BF4]), sodium hydroxide (NaOH), hydrochloric acid (HCl), 
dichloromethane (DCM), and acetone were purchased from Sigma-Aldrich (St. Louis, MO) and 
were used as received. Triply deionized water (18.2 MΩ) was obtained using an Elga Genetic 
Ultra-Pure water polishing system obtained from US Filter (Lowell, MA, USA). 
3.2.2 Characterization 
The infrared absorption measurements of GUMBOS and nanoGUMBOS were performed 
using a Lambda 750 UV-Vis-NIR Spectrophotometer (Perkin-Elmer, Waltham, MA, USA) using 
a 1 cm pathlength quartz cuvette.  Structural characterizations of these GUMBOS were 
elucidated by use of the following instrumentation: 
1
H NMR Brüker DPX-400 (400 MHz) and 
19
F NMR Brüker DPX-250 (250 MHz). The sizes and images of these nanoGUMBOS were 
acquired by use of a JEOL JEM-1011 (Peabody, MA, USA) transmission electron microscope. 
The zeta potentials of the nanoGUMBOS were obtained using a DTS1061 capillary cell in a 
Zetasizer Nanoseries Nano ZS (Malvern Instruments, Worcestershire, UK) instrument. The 
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melting points for these GUMBOS were measured in triplicate using a Digimelt MPA160 
melting point apparatus (Stanford Research Systems Inc., Sunnyvale, CA, USA). The heat 
capacities (Cp) for the GUMBOS were measured by a modulated differential scanning 
calorimeter, model: DSC2920, (TA Instruments, New Castle, DE, USA) in hermetic aluminum 
pans (p/n: V0804805, Thermal Support, Lawrenceville, GA, USA). 
3.2.3 Synthesis of GUMBOS and NanoGUMBOS 
Scheme 3.1 Metathesis synthesis for the [1048] and [1061] GUMBOS were performed by an 
anion exchange method. 
 
GUMBOS used in this study were synthesized via an anion exchange method (Scheme 
3.1). Cationic dyes were individually dissolved in dichloromethane and mixed with aqueous 
anionic precursor salts in a 1:1.1 (mol:mol) ratio. These materials were then allowed to stir for 
two days while wrapped in aluminum foil to avoid photobleaching. These newly synthesized 
GUMBOS were washed three times with water, followed by decanting the water, and removing 
the solvent by use of a rotovap. NanoGUMBOS were synthesized by use of a reprecipitation 
method employing a High Intensity Ultrasonic Processor VC 750 (Sonics & Materials Inc., 
Newton, CT). The aqueous suspension was adjusted to variable pH values (2.0, 5.0, 7.0, 9.0, and 
11.0) using HCl and NaOH prior to the formation of nanoGUMBOS. These GUMBOS were then 
dissolved in acetone at a concentration of 2 mM with an injection volume of 150 µL into 5 mL of 
(1) Dichloromethane
(2) Na[Anion] (aq)
(3) Wash
(4) Purify
(1) Dichloromethane/ 
Na[Ascorbate] (aq)
(2) as
(3) Purify
 i l /
Na[Anion] (aq)
(2) Wash and Purify 
(1) Dichloromethane
(2) Na[Anion] (aq)
(3) Wash
(4) Purify
(1) Dichloromethane/ 
Na[Ascorbate] (aq)
(2) as
(3) Purify
[Anion]
(1) Dichloromethane
(2) Na[Anion] (aq)
(3) Wash
(4) Purify
(1) Dichloromethane/ 
Na[Ascorbate] (aq)
(2) as
(3) Purify
 i l /
Na[Anion] (aq)
(2) Wash and Purify 
(1) Dichloromethane
(2) Na[Anion] (aq)
(3) Wash
(4) Purify
(1) Dichloromethane/ 
Na[Ascorbate] (aq)
(2) as
(3) Purify
[Anion]
(1) Dichlorom thane
(2) Na[A ion] (aq)
(3) Wash
(4) Purify
(1) Dichloromethane/ 
Na[Ascorbate] (aq)
(2) as
(3) Purify
 i l /
Na[Anion] (aq)
(2) W sh and Purify 
(1) Dichlorom thane
(2) Na[Anion] (aq)
(3) Wash
(4) Purify
(1) Dichloromethane/ 
Na[Ascorbate] (aq)
(2) as
(3) Purify
[Anion]
(1) Dichloromethane
(2) Na[Anion] (aq)
(3) Wash
(4) Purify
(1) Dichloromethane/ 
Na[Ascorbate] (aq)
(2) as
(3) Purify
 i l /
Na[Anion] (aq)
(2) Wash and Purify 
(1) Dichloromethane
(2) Na[Anion] (aq)
(3) Wash
(4) Purify
(1) Dichloromethane/ 
Na[Ascorbate] (aq)
(2) as
(3) Purify
[Anion]
[1048]
[1061]
 75 
 
an aqueous suspension jacketed in ice to minimize overheating for the 10 minutes of continuous 
probe sonication. Following sonication, the newly formed nanoGUMBOS were allowed to 
equilibrate under ambient conditions in the dark for five days prior to characterization and 
further analyses. 
3.2.4 Laser Irradiation 
GUMBOS and nanoGUMBOS were irradiated using an infrared (1064 nm) diode-
pumped solid state (Nd:YVO4) laser (Lasermate Group Inc., Pomona, CA, USA) at variable 
power intensities for five minutes and measured by use of a Thermovision A40 thermal imaging 
camera and the ThermoCAM™ Researcher 2.8 SR-1 software (FLIR Systems Inc., Boston, MA, 
USA). Bulk GUMBOS were irradiated at the following four power intensities: 250, 500, 750, 
and 1000 mW. Bulk GUMBOS (4 mg) were placed on a watch glass orthogonal to the 
thermocamera. The laser was aligned 80° from the sample at a distance of 15 cm. The presented 
angle resulted in a laser spot having a diameter of approximately 2 mm. The power intensity at 
250, 500, and 750 mW for the nanoGUMBOS did not yield a substantial increase in temperature; 
therefore, only 1000 mW power intensity is reported. The nanoGUMBOS photothermal 
responses were measured in a 1 x 1 cm fluorescence quartz cuvette at a volume of 500 µL. 
3.3 Results and Discussion 
3.3.1 Characterization of NIR GUMBOS and NanoGUMBOS 
Preliminary structural information of the GUMBOS were elucidated by use of 
1
H and 
19
F 
NMR. Use of 
19
F NMR confirmed a complete anion exchange and successful removal of the 
starting material, tetrafluoroborate, as indicated by the absence of a fluorine peak. The 
1
H and 
19
F 
NMR spectroscopy data of the four synthesized GUMBOS are provided in Appendix, Figures 
A3.1 A-F. Fourier Transform Infrared (FTIR) spectroscopy elucidation studies were also 
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performed to observe the protonation/deprotonation of anions when NIR nanoGUMBOS were 
synthesized at various pH values (Appendix, Figure A3.2 A-D). The FTIR absorbencies of the 
nanoGUMBOS were measured in the synthesis medium. The synthesis of nanoGUMBOS at 
various pH values (i.e. 2.0, 5.0, 7.0, 9.0, and 11.0) resulted in different shapes and sizes as 
determined by TEM. It was noticed that the nanoGUMBOS synthesized in a medium of pH 2 
typically formed nanorods opposed to the nanoGUMBOS synthesized in the other pH media. 
The zeta potential of the nanoGUMBOS was measured as this is an important factor determining 
the stability of these colloidal systems. This is because increasing the positive or negative charge 
of the nanoGUMBOS will result in more stable particles due to enhanced repulsion among the 
particles,
25
 while smaller zeta potentials indicate instability of the suspension leading to the 
aggregation of the particles. 
3.3.1.1 [1048][Deoxycholate] 
 
Figure 3.1 Representative TEM images of [1048][Deoxycholate] NIR nanoGUMBOS prepared 
in different pH media yielded different sizes and shapes (scale bars are 100 nm). 
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The nanoGUMBOS synthesized in pH 2.0 media resulted in rod-like shapes (Figure 3.1). 
These precipitated nanorods are believed to be solely composed of the cation, [1048], ionically 
bound to a chloride anion. It is likely that at a low pH the anions are protonated based on their 
pKa values (Scheme 3.2).
26
 The chloride anion would thermodynamically favor the ionic bond 
with the cation dyes due to the excessive concentration of the chloride anion creating, 
[1048][Cl]. The protonated “would-be” anion (i.e. [Deoxycholate]) becomes water soluble, 
resulting in solely [1048][Cl] precipitating into nanorods. The rods formed at pH 2.0 for the 
[1048][Cl] nanoGUMBOS were dispersed with a resulting diameter of 23.5 ± 10.4 nm. 
Scheme 3.2 The protonation to deprotonation of desired anions (A, Deoxycholate; B, Ascorbate) 
and their respective pKa help to gain understanding of the nanoGUMBOS structural formation. 
 
The higher pH media that the nanoGUMBOS were synthesized in resulted in spherical-like 
shapes due to the ionic coordination of the intended anion (i.e. [Deoxycholate]). The 
nanoGUMBOS synthesized at pH 5.0 strongly aggregated (53.4 ± 7.4 nm) due to the anions pka 
of 6.6 and low zeta potential of +6.25 mV. Deprotonation of an anion occurs when 
nanoGUMBOS are synthesized near the pKa of the anion. The deprotonation of the anions 
4.2 11.6
6.6
(B)
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resulted in the formation of spherical shapes rather than rods as seen at pH 2.0. The FTIR studies 
were observed from the aqueous media to measure the protonation and deprotonation of the 
anions (Appendix, Figure A3.2A). The [1048][Cl] at pH 2.0 shows the strong –C-OH in-plane 
bends at 1420 and 1467 cm
-1
 for deoxycholic acid, while at pH 5.0 only one peak at 1427 cm
-1
 
corresponding to [Deoxycholate]. The –C(=O)-O- and –C-O- stretches had a difference in 
intensities between nanoGUMBOS suggesting protonation-deprotonation of the anion in the two 
different pH media (i.e. pH 2 and 5). When the pH is above the pKa of deoxycholate (i.e. pH 7), 
the nanoGUMBOS become less aggregated and more stable having a size distribution of 117.9 ± 
35.3 nm, and a zeta potential of +11.2 mV. At pH 9.0 and 11.0 the nanoGUMBOS are more 
aggregated with respective sizes for pH 9 and 11 of 12.7 ± 7.2 nm and 20.7 ± 5.4 nm. The 
aggregation of nanoGUMBOS synthesized in pH 9.0 and 11.0 media is likely the result of the 
respective small zeta potentials of +3.98 and -7.07 mV. The FTIR spectra for these 
nanoGUMBOS do not seem to differ significantly in terms of peak shifts or intensities, 
indicating little change in molecular structure. 
3.3.1.2 [1048][Ascorbate] 
The [1048][Ascorbate] nanoGUMBOS formed globular rod-like structures when 
synthesized in an aqueous medium at pH 2.0 (Figure 3.2). Similar to the aforementioned 
nanoGUMBOS, [1048][Deoxycholate], it is believed that these rods are entirely composed of 
[1048][Cl] due to the over abundance of chloride anion in this very acidic environment. These 
globular structures had an average diameter of 357 ± 38 nm, while the diameters of the rods were 
48.5 ± 12.7 nm. 
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Figure 3.2 TEM images of [1048][Ascorbate] NIR nanoGUMBOS prepared in different pH media 
yielded different sizes and shapes (scale bars are at 100 nm). 
 
According to the FTIR spectrum the ascorbate anion is completely protonated when the 
nanoGUMBOS were synthesized in pH 2.0 as indicated by the doublet in-plane C-O-H bend at 
1429 and 1460 cm
-1
 (Appendix, Figure A3.2B). When synthesized in an increased pH media (pH 
5.0) the absence of the 1460 cm
-1
 bend and a more pronounced 1424 cm
-1
 bend indicated 
deprotonation of the hydroxyl group, thus allowing the formation of an ionic bond with the 
[1048] cation. At this pH, aggregation of particles (142 ± 21.4 nm and zeta potential of -19.5 
mV) occurs due to their instability in an acidic environment near the pKa of ascorbate 4.2. It was 
observed that nanoGUMBOS synthesized near the pKa of their anions tend to show more 
aggregation and less particle stability. The observed phenomenon can be attributed to partial 
dissociation of the anion due to protonation of the carboxylic groups. This in turn results in an 
increase in the sole anions hydrophilicity; unlike when the anion is ionically bound to the 
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intended cation making the molecule hydrophobic. The [1048][Ascorbate] nanoGUMBOS 
synthesized in pH 7.0 media resulted in monodispersed particles of 49.7 ± 11.3 nm and a zeta 
potential of +34.7 mV. The monodispersity of the pH 7.0 nanoGUMBOS is well-supported by 
the high zeta potential, suggesting that these particles have a high positive surface charge and 
therefore have stable repulsion forces. In basic environments at pH 9.0 and 11.0, the aggregated 
nanoGUMBOS (27.4 ± 5.4 and 39.0 ± 8.8 nm, respectively) experienced poor stability. These 
zeta potentials for the pH 9.0 and 11.0 nanoGUMBOS (+19.4 and +17.9 mV, respectively) are in 
agreement with the particles colloidal instability. The [1048] nanoGUMBOS synthesized in the 
various pH media had lower net surface charges in pH media 5.0, 9.0, and 11.0 resulting in 
nanoparticle aggregation (Table 3.1). 
Table 3.1 A compiled list of the [1048] nanoGUMBOS spectral and morphological 
characteristics for [Deoxycholate] and [Ascorbate], respectively, show a trend of aggregation and 
zeta-potential with an increased pH media. The bold lines represent the divisions of pKa values. 
 
 
3.3.1.3 [1061][Deoxycholate] 
The [1061][Deoxycholate] nanoGUMBOS, synthesized at pH 2.0 formed globular rod 
structures similarly to the [1048] nanoGUMBOS at pH 2.0  (Figure 3.3). The average diameters 
pH Size (nm) Aggregation Zeta Potential (mV) Absorbance (1064 nm) ∆T Irradiation (°C)
 GUMBOS      
Photothermal Efficiency %
2 23.5 No 56.2 0.1469 19.00
5 53.4 Yes 6.25 0.1849 13.30
7 117.9 No 11.2 0.1674 18.02
9 12.7 Yes 3.98 0.2254 19.57
11 20.7 Yes -7.07 0.2168 16.08
[1048][Deoxycholate] - pKa 6.6
19.66
pH Size (nm) Aggregation Zeta Potential (mV) Absorbance (1064 nm) ∆T Irradiation (°C)
 GUMBOS      
Photothermal Efficiency %
2 357 No 44.8 0.1731 18.02
5 142 Yes -19.5 0.0583 23.78
7 49.7 No 34.7 0.0266 20.80
9 27.4 Yes 19.4 0.0405 20.88
11 39.0 Yes 17.9 0.0562 21.56
[1048][Ascorbate] - pKa 4.2, 11.6
64.39
 81 
 
of these rods are 35.2 ± 13.3 nm that made a cluster of rods (228 ± 49 nm). The zeta potential of 
the globular structures is high at +43.9 mV and suggests that this is a stable conformation. 
 
Figure 3.3 The NIR nanoGUMBOS, [1061][Deoxycholate] prepared in different pH media 
yielded different sizes and shapes (scale bars are at 100 nm). 
The FTIR spectra for these nanoGUMBOS synthesized in pH 2.0 and 5.0 showed similar 
molecular changes as the aforementioned [1048] nanoGUMBOS with [Deoxycholate] anion 
(Appendix, Figure A3.2C), suggesting [1061][Cl] as the precipitating nanoGUMBOS in pH 2 
aqueous medium. For pH values of 5.0, 7.0, 9.0, and 11.0, the respective size distributions for 
each synthesized nanoGUMBOS are 84.1 ± 21.2, 8.8 ± 1.7, 142.5 ± 40.5, and 55.0 ± 10.3 nm. 
The nanoGUMBOS synthesized at increased pH values were observed to be monodispersed with 
very limited aggregation which correlated well with respective zeta potentials of -39.4, -13.0, -
7.87, and -34.7 mV at pH 5.0, 7.0, 9.0, and 11.0. The FTIR spectra for the nanoGUMBOS 
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synthesized in pH 7.0, 9.0, and 11.0 media suggest that the [1061] cation has an ionic bond to the 
[Deoxycholate] anion (Appendix, Figure A3.2C). 
3.3.1.4 [1061][Ascorbate] 
 
Figure 3.4. The NIR nanoGUMBOS, [1061][Ascorbate] prepared in different pH media yielded 
different sizes and shapes (scale bars are at 100 nm). 
Synthesis of [1061][Ascorbate] nanoGUMBOS at pH 2.0 formed rods (38.8 ± 12.9 nm), 
but did not aggregate the rods into globular structures as seen with for other nanoGUMBOS 
(Figure 3.4). The zeta potential for the stable nanoGUMBOS in pH 2.0 media was +43.2 mV. 
The FTIR spectrum for the [1061][Ascorbate] nanoGUMBOS was similar to the 
[1048][Ascorbate] nanoGUMBOS due to the [Ascorbate] anion protonation, which resulted in a 
precipitated formation of [1061][Cl] (Appendix, Figure A3.2D). Nevertheless, protonation of the 
[Ascorbate] anion was not shown to take place with the nanoGUMBOS synthesized in pH 5.0, 
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7.0, 9.0, and 11.0 media. The respective particle sizes for nanoGUMBOS synthesized in pH 5.0, 
7.0, 9.0, and 11.0 media are 5.0 ± 1.3 nm, 36.3 ± 8.7 nm, 22.5 ± 5.6 nm, and 8.3 ± 4.2 nm. These 
nanoGUMBOS were very stable within their respective media having zeta potentials of -33.0, 
+29.8, -37.4, and -16.0 mV. The nanoGUMBOS that ionically bonded to the [1061] cation were 
observed to have more spherical, stable, and less aggregated particles unlike the [1048] cation 
counterpart. The surface charges were high enough to prevent nanoparticle aggregation for the 
[1061] nanoGUMBOS when synthesized in different pH media (Table 3.2). 
Table 3.2 A compiled list of the [1061] nanoGUMBOS spectral and morphological 
characteristics for [Deoxycholate] and [Ascorbate], respectively, show a trend of aggregation and 
zeta-potential with an increased pH media. The bold lines represent the divisions of pKa values. 
 
 
 
3.4 Photospectral Characteristics of GUMBOS & NanoGUMBOS 
An 80 µM concentration of bulk GUMBOS dissolved in acetone had absorbance maxima 
near their intended absorbance as shown in Figure 3.5. The [1048] GUMBOS’ exhibited slight 
blue shifts due to the change in ionically-bound anions from the starting material (e.g [BF4], 
1042 nm). This shift can be attributed to π-π stacking from the aromatic rings during 
dimerization self-assembly.
27-29
 However, the [1061] GUMBOS’ did not exhibit shifts of 
pH Size (nm) Aggregation Zeta Potential (mV) Absorbance (1064 nm) ∆T Irradiation (°C)
 GUMBOS      
Photothermal Efficiency %
2 228 No 43.9 0.1184 26.16
5 84.1 No -39.4 0.1495 24.77
7 8.8 No -13.0 0.1674 23.36
9 142.5 No -7.87 0.1500 19.84
11 55.0 No 34.7 0.1530 24.48
[1061][Deoxycholate] - pKa 6.6
13.03
pH Size (nm) Aggregation Zeta Potential (mV) Absorbance (1064 nm) ∆T Irradiation (°C)
 GUMBOS      
Photothermal Efficiency %
2 38.8 No 43.2 0.0505 17.99
5 5.0 No -33.0 0.0831 19.57
7 36.3 No 29.8 0.0809 20.49
9 22.5 No -37.4 0.0569 16.21
11 8.3 No -16.0 0.0832 23.26
20.70
[1061][Ascorbate] - pKa 4.2, 11.6
 84 
 
absorbance maximum, but rather slight spectral changes. These spectral phenomena for the 
[1061] GUMBOS were similarly seen with the [1061] nanoGUMBOS (Figures 3.5 & 3.6); 
however, the absorbance maxima of nanoGUMBOS relative to GUMBOS red-shifted once 
synthesized.
29
 The [1048] nanoGUMBOS maintained their absorbance spectral characteristic 
while the [1061] nanoGUMBOS lacked in clearly defined absorbance peaks (Figure 3.6). 
  
Figure 3.5 The GUMBOS were dissolved in acetone at a concentration of 80 μM and 
absorbance normalized. (A) [1048] GUMBOS maxima were, respectively, 1035 and 1045 nm. 
(B) [1061] GUMBOS apexes were at 1045 nm. 
 
Figure 3.6 The [1048] nanoGUMBOS showed spectral shifts among different pH, while it was 
difficult to ascertain with the [1061] nanoGUMBOS. 
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The defined spectral characteristic shape and a trend in apex shift of absorbance of the 
[1048] nanoGUMBOS were maintained with increased pH values. The absorbance spectrum for 
[1061] nanoGUMBOS exhibited a broadening previously encountered in nanoGUMBOS 
attributed to dye aggregation.
30
 The absorbance red-shifted for [1048][Deoxycholate] 
nanoGUMBOS as the pH of the aqueous media increased (Figure 3.7). Absorbance for 
[1048][Ascorbate] nanoGUMBOS in a pH 5 aqueous media was recorded at 1117 nm, however, 
with an increase in pH aqueous media the absorbance maxima blue-shifted (i.e. pH 11 = 1104 
nm). The aggregation of the nanoGUMBOS, shapes, and sizes are possibly the cause for this 
spectral phenomenon. The wavelength of interest for these nanoGUMBOS is the emission 
wavelength of the Nd:YVO4 (i.e. 1064 nm) used to create a photothermal response. 
 
Figure 3.7 The nanoGUMBOS showed an inverse parabola trend of absorbance maximum with 
an increase in pH between the pKa values (grey vertical dashes). 
3.5 Photothermal Characteristics 
The bulk solid GUMBOS achieved temperatures between 200 – 500 °C within the first 
10 seconds of continuous NIR irradiation at 1000 mW for 4 milligrams of sample. The 
[1048][Ascorbate] reached a temperature of 511 ± 41.9 °C, and the [1048][Deoxycholate] 
GUMBOS reached a temperature of 411 ± 70.3 °C after five minutes continuous NIR irradiation 
(Figure 3.8A). The bulk GUMBOS ionically bound to the [1061] cation yielded lower 
photothermal temperatures upon NIR irradiation (Figure 3.8B). The [1061][Deoxycholate] 
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yielded a temperature of 310 ± 46.3 °C, and [1061][Ascorbate] achieved a temperature of 267 ± 
44.3 °C after five minutes. 
 
 
Figure 3.8 Photothermal profile of a 4 mg bulk (A) [1048] and (B) [1061] GUMBOS sample 
under continuous NIR irradiation for five minutes at a 1000 mW shows a dramatic temperature 
increase. 
The photothermal response from 1000 mW of laser irradiation after five minutes on 0.500 
mL aqueous suspension nanoGUMBOS sample shared parabola-like trends among the respective 
nanoGUMBOS in their pH media and their anions respective pKa values (Figures 3.9 and 3.10). 
The [1048] nanoGUMBOS overall averaged a temperature increase of 20.6°C. 
[1048][Ascorbate] in pH 5 transducing the most amount of heat difference at 23.8 °C, and 
[1048][Deoxycholate] in pH 11.0 with the least at 16.1 °C (Table 3.1). 
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Figure 3.9 The absorbance at 1064 nm and photothermal response shows a trend as pH increases 
among the (A) [1048][Deoxycholate] and (B) [1048][Ascorbate] nanoGUMBOS. 
 
Figure 3.10 The absorbance at 1064 nm and photothermal response shows a trend as pH 
increases among the (A) [1061][Deoxycholate] and (B) [1061][Ascorbate] nanoGUMBOS. 
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Figure 3.10 Continued. 
 
Among the [1048] anions, [1048][Ascorbate] generated a higher photothermal response at 21.0 
°C, while [1048][Deoxycholate] at released 17.2 °C. The photothermal efficiencies (η) of the 
nanoGUMBOS were calculated using equation 3.1 established by Roper et al.
31
 
  
             
             
                            Equation 3.1 
Herein, h is the heat transfer coefficient and S is the surface area of the cuvette that the 
nanoGUMBOS suspension was studied. TG was the highest photothermal temperature recorded 
from the GUMBOS, and the TST was the temperature of the GUMBOS prior to irradiation. Q0 is 
the thermal energy obtained from the quartz cuvette which was found to be negligible for our 
wavelength of interest unlike previous studies.
16, 31-32
 I is the incident laser power (1 W), and A is 
the absorbance of the nanoGUMBOS at the laser’s excitation wavelength, 1064 nm. The hS 
component was derived from equation 3.2 and the slope, τs, of time vs Ln(Θ) using the 
temperature increase upon laser irradiation (Figures 3.11). 
    
    
  
        Equation 3.2 
In equation 3.2, m is the mass of the nanoGUMBOS in the sample, and Cp is the experimentally 
determined heat capacity for the GUMBOS (Table 3.3). Because the heat capacities were 
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measured using bulk GUMBOS opposed to suspended nanoGUMBOS, the photothermal 
efficiency variables were taken from the bulk measurements since the photoreaction chemistry 
occurs directly on the material. 
 
Figure 3.11 The slope of natural log of the driving force temperature versus time is an integral 
component for finding the photothermal efficiency of the nanoGUMBOS. 
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Table 3.3 The heat capacities (Cp) for the GUMBOS were experimentally determined in 
triplicate by a modulated DSC instrument. 
 
Heat Capacity (Cp) J/(g °C) 
GUMBOS at 25 °C at 40 °C at 50 °C at 60 °C at 70 °C 
[1048][Deoxycholate] 0.9240 0.9805 1.0420 1.1335 1.1985 
[1048][Ascorbate] 1.0877 1.1437 1.1893 1.2367 1.2787 
[1061][Deoxycholate] 0.8184 0.8598 0.8880 0.9180 0.9504 
[1061][Ascorbate] 0.8204 0.8552 0.8898 0.9207 0.9675 
 
The dimensionless driving force temperature, Θ, was calculated using the room temperature, 
TRT, along with a control temperature increase of the [Anion] independent from the [Cation], TA, 
in equation 3.3: 
  
      
      
         Equation 3.3 
A correlation was not observed with the photothermal response of the nanoGUMBOS 
with aggregation and size. It was noticed, however, that the [1048] and [1061] cations ionically 
bound to [Ascorbate] were more photothermally efficient when converting NIR light energy into 
thermal energy. The [1048][Ascorbate] and [1061][Ascorbate] were calculated from the bulk 
materials as having a photothermal efficiency of 64.4% and 20.7%, respectively. The less 
efficient GUMBOS, [1048][Deoxycholate] and [1061][Deoxycholate], were calculated to have a 
photothermal efficiency of 19.7% and 13.0%, respectively. This can be explained by dissecting 
the efficiency equation and qualitatively recognizing that those nanoGUMBOS had a lower 
absorbance value at the lasers wavelength. Speculation can be made about the higher 
photothermal efficiency due to the conjugate double bond in [Ascorbate]. The conjugated double 
bond decreases the highest occupied molecular orbital (HOMO) and lowest unoccupied 
molecular orbital (LUMO) band gap; therefore, requiring lesser energy to promote the electron 
upon excitation.
33-34
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3.6 Band Gap Calculations 
 Band gap distance is important in the understanding of how efficiently a photon can 
promote an electron from the HOMO to the LUMO.
35
 Manipulating or using a compound that 
has a smaller band gap has been shown to increase the fluorescence efficiency,
36
 or in this case 
the photothermal efficiency (Table 3.4). Calculating the band gap energies (eV) were performed 
by inserting absorbance onset (λonset) values from the aqueous suspension of nanoGUMBOS in 
equation 3.4:
34, 37-38
 
     
  
      
     Equation 3.4 
The constants in the equation are the speed of light (3.00 x 10
8
 m s
-1), c, and Planck’s constant, h 
(4.136 x 10
-15
 eV · s). The following are the trends for GUMBOS band gap energy relative to 
photothermal efficiency: 
 
The four GUMBOS coincide with literature understanding of how electron withdrawing groups 
are typically more photo-efficient.
33-34, 37-38
 By examining the molecular structure of the cations, 
[1048] and [1061], it is noticed that nitrogen and sulfur atoms exist in the ring systems, 
respectively. According to the electronegativity Pauling scale nitrogen is χ=3.04, and sulfur is 
2.58.
26
 The more electron pull of the nitrogen in concert with two additional chlorine atoms 
(χ=3.16) gives the [1048] cation a slightly smaller band gap than the [1061] cation as observed in 
previous literature.
39
 The [Ascorbate] anion is more electron withdrawing than the 
[Deoxycholate] anion due to more oxygen atoms (χ=3.44) with a carbonyl and an oxygen within 
the conjugated lactone system. The electronegative atoms and electron withdrawing groups have 
Increasing Photothermal Efficiency
Increasing Band Gap Energy
 1048  𝐴𝑠𝑐𝑜𝑟𝑏𝑎𝑡𝑒 −  1061  𝐴𝑠𝑐𝑜𝑟𝑏𝑎𝑡𝑒 −  1048  𝐷𝑒𝑜𝑥𝑦𝑐 𝑜𝑙𝑎𝑡𝑒 −  1061 [𝐷𝑒𝑜𝑥𝑦𝑐 𝑜𝑙𝑎𝑡𝑒] 
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led to the decrease in band gap energies, thus allowing for more photothermal efficient 
GUMBOS. 
Table 3.4 Photothermal efficiency (η) increases as band gap energy (eV) decreases due to the 
GUMBOS electron withdrawing groups. 
 
3.7 Conclusion 
NIR nanoGUMBOS were studied for characterization of photothermal effects and 
nanoparticle formation in different pH media. The NIR nanoGUMBOS formed nanorods when 
synthesized in a pH media of 2.0, which protonated the anions and forcing the cations to 
ionically bind to excess chloride anion. The data suggests that the surface charge required to 
limit aggregation for each type of nanoGUMBOS is different for each compound. For example, 
[1061] nanoGUMBOS had more stable surface charge resulting in limited nanoparticle 
aggregation. Nevertheless, [1048] nanoGUMBOS had higher electronegativity resulting to 
smaller band gap energies, thus higher photothermal efficiencies. The GUMBOS with the 
[Ascorbate] anion exhibited higher photothermal efficiency than the [Deoxycholate] anion due to 
smaller band gap energy from the electron withdrawing groups. This study helps provide a 
physical understanding of GUMBOS based photothermal materials for the potential use as 
hyperthermal therapeutics. 
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Chapter 4. Tumor-Targeting Hyperthermal Near-Infrared NanoGUMBOS 
 
4.1 Introduction 
The American Cancer Society estimates that more than two million new cases of cancer 
will be recorded in 2012. Fortunately, only about 32% of the victims will become terminal due to 
the increasing and successful cancer research being performed.
1
 One of the oldest therapeutics 
for cancer treatments dating back to antiquity is the use of cauterization, or heat.
2
 Heat to destroy 
cancerous tumors is practiced presently, but less invasive using photothermal nanoparticles 
generated from radiowaves,
3
 microwaves,
4
 magnetic field,
5
 or near infrared laser.
6
 Nanoparticles 
such as gold
7-8
 and porphysomes have provided greater than the necessary temperature threshold 
of 41 – 45 °C to initiate cancer cell death.9-10 These nanoparticles underwent photothermal 
conversion when subjected to near infrared (NIR) laser light. NIR laser irradiation is 
advantageous due to the human skin weakly absorbent window between wavelength ranges 750 
– 1100 nm.11 Many cancer therapeutic nanoparticles conjugate folate molecules to selectively 
target cancer cells.
12-13
 Folate (or vitamin B9) is used to synthesize DNA, repair DNA, and for 
cell proliferation.
14
 The cellular division process is facilitated by folic acid, because cancer cells 
divide uncontrollably thus having an overexpression of folate-receptor alpha proteins.
15
 The 
folate molecule has a large affinity towards this protein; hence using it is a targeting agent. The 
plethora of percutaneous hyperthermia techniques demonstrates promising methods for cancer 
therapy. 
A new class of nanomaterials has been derived from a group of uniformed materials 
based on organic salts (GUMBOS). GUMBOS have a unique set of properties such as limited 
volatility, variable viscosity and solubility, and melting temperature range of 25 – 250 °C. By 
performing a metathesis reaction properties are tunable depending on the ionic species whether 
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the cations and/or anions are fluorescent,
16-19
 magnetic,
19-21
 chiral,
18, 21-22
 and antibiotic.
23
 
GUMBOS have been further synthesized into nanomaterials (nanoGUMBOS) to increase surface 
area, thus allowing for more potential of the desired property. These facile tunable compounds 
have allowed for a vast number of possible applications towards areas of solar cells,
24
 sensors,
25
 
separations, and biomedical.
16, 19, 23
 Herein, a hyperthermal technique involving laser irradiation 
to generate heat photothermally from a GUMBOS-based near infrared cationic dye and tumor-
targeting folate anion is presented. 
4.2 Materials and Characterization 
4.2.1 Materials 
The following chemicals were purchased from Sigma-Aldrich (St. Louis, MO) without further 
purification: folic acid, 1-Butyl-2-[2-[3-[(1-butyl-6-chlorobenz[cd]indol-2(1H)-
ylidene)ethylidene]-2-chloro-1-cyclohexen-1-yl]ethenyl]-6-chlorobenz[cd]indolium 
tetrafluoroborate ([1048][BF4]) and 4-[2-[2-Chloro-3-[(2,6-diphenyl-4H-thiopyran-4-
ylidene)ethylidene]-1-cyclohexen-1-yl]ethenyl]-2,6-diphenylthiopyrylium tetrafluoroborate 
([1061][BF4]), 18.2 MΩ water, sodium hydroxide (NaOH), dichloromethane (DCM), dimethyl 
sulfoxide (DMSO), and acetone. AlamarBlue® assay, LIVE/DEAD® Viability/Cytotoxicity Kit 
(live: calcein-AM and dead: ethidium homodimer-1), and Dulbecco's Modified Eagle Media 
(DMEM) were purchased from Life Technologies Corporation (Grand Island, NY). The DMEM 
was modified with 10% Fetal Bovine Serum, 15 mM HEPES, glutamax 100X, non-essential 
amino acids (NEAA 100X), and sodium pyruvate (NaPyr 100X). Phosphate buffer saline (PBS) 
was purchased from Fisher Scientific: BioReagents (Fair Lawn, NJ).  
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4.2.2 Characterization 
The GUMBOS and nanoGUMBOS infrared absorption measurements were characterized 
by a Lambda 750 UV-Vis-NIR Spectrophotometer (Perkin-Elmer, Waltham, MA, USA) using a 
1 cm pathlength quartz cuvette. Structural characterizations of the GUMBOS were elucidated by 
the following instruments: Agilent 6210 Electrospray Time-of-Flight Mass Spectrometer, 
19
F 
NMR Brüker DPX-250 (250 MHz). Transmission electron microscopy (TEM) images were 
taken using a JEOL JEM-1011 at the School of Veterinary Medicine (LSU). Dynamic light 
scattering (DLS) studies were performed with a Zetasizer Nanoseries Nano ZS (Malvern 
Instruments, Worcestershire, UK) instrument. Fluorescence intensity from the cell assays were 
recorded from a Wallace Victor2™ (Perkin-Elmer, Waltham, MA, USA) plate reader. 
Visualizations of the fluorescent live/dead probes were observed by an Olympus IX81 
microscope and Hammamatsu C4742 fluorescence detector. 
4.2.3 Synthesis of GUMBOS and NanoGUMBOS 
Folic acid was synthesized into sodium folate by a 1:1 mol:mol ratio of folic acid and 
NaOH. Sodium folate confirmation was supported by electrospray mass spectrometry (ESI MS) 
(Appendix, Figure A4.1). The ESI MS spectrum shows that the folate peak (m/z = 464) was 
about half of the folic acid peak (m/z = 442), suggesting that only half of the reactant was 
deprotonated forming sodium folate. The GUMBOS were synthesized via anion exchange 
method. The cationic dyes were individually dissolved in DCM and mixed with the aqueous 
anionic precursor salts in a 1:2 mol:mol ratio (Scheme 4.1). The materials were then allowed to 
mix thoroughly for two days wrapped in aluminum foil to avoid photobleaching prior to washing 
and purification. The newly synthesized GUMBOS were washed three times and then stored in 
100 
 
the dark at ambient temperatures. Successful metathesis reactions were supported by 
19
F NMR 
(Appendix, Figure A4.2).  
Scheme 4.1 A metathesis reaction exchanging a folate anion with tetrafluoroborate was done in a 
1:2 mol:mol ratio. 
 
 
NanoGUMBOS were synthesized by a microwave-assisted reprecipitation method in 
triply distilled 18.2 MΩ water. The GUMBOS were dissolved in acetone at concentration of 2 
mM and injected accordingly to have final nanoGUMBOS concentration of 320 µg mL
-1 
in 5 mL 
of an aqueous suspension. The microwave parameters were set to ramp quickly to 150 °C and 
hold for five minutes. The nanoGUMBOS product was drop-cast on a 400 mesh ultrathin 
carbon-film copper TEM grid (Ted Pella Inc., Redding, CA, USA) and DLS was measured. 
4.3 Methods 
4.3.1 Laser Irradiation 
Laser irradiation source was from an infrared (1064 nm) diode-pumped continuous solid-
state Nd:YVO4 laser (Lasermate Group Inc., Pomona, CA, USA). The variable concentrations of 
nanoGUMBOS were subjected to NIR laser irradiation for at least 30 minutes. Incremental 
volumes (i.e. 0, 32, 64, and 128 µL) of 320 µg mL
-1 
nanoGUMBOS were added to a glass NMR 
tube filled with 100 µL of DMEM media. The final nanoGUMBOS concentrations were the 
1:2 mol:mol
[1061][BF4]in DCM
Na[Folate] (aq)
1:2 mol:mol
[1048][BF4]in DCM
Na[Folate] (aq)
(A)
(B)
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following, respectively: 0, 77.6, 124.9, and 179.6 µg mL
-1
.  The samples experienced a 2 mm 
diameter focal spot of NIR laser irradiation in triplicates at a power of 32 W cm
-2
, and measured 
with a TA (Thermal Analysis) Instruments Thermacouple and Universal Analysis 2000 program 
(version 4.3A) (Appendix, Figure A4.3). 
4.3.2 Cytotoxicity/NanoGUMBOS Control 
Cytotoxicity of nanoGUMBOS in malignant MDA-MB-231 breast cancer cells were 
studied using a concentration of 10,000 cells. The cytotoxicity of nanoGUMBOS were studied in 
a concentration of 5,000 normal breast cells, HS-578-BST. Live and dead (3% H2O2 injection) 
controls for both cell lines were administered. All cells were incubated at 32 °C and 5% CO2 in 
100 µL modified DMEM and studied in a 96 well-plate with optically clear bottoms and 
performed in triplicate. Different volume increments (i.e. 4, 16, 32, 64, and 128 µL) of 320 µg 
mL
-1 
nanoGUMBOS were added in triplicates to individual wells of 100 µL DMEM leading to a 
final concentration of 12.3, 44.1, 77.6, 124.9, and 179.6 µg mL
-1
. The nanoGUMBOS were 
allowed to incubate for 24 hours before preparing the alamarBlue® assay. The medium was 
removed and washed with PBS solution. The cells were incubated in 100 µL of 10% (v/v) 
alamarBlue® dye in DMEM media (AB/DMEM) for eight hours. Incubation for eight hours of a 
concentration of 10,000 cells was determined appropriately for the cells (Appendix, Figure 
A4.4). The alamarBlue® dye (resazurin) is nonfluorescent in an oxidized environment, but 
fluorescent (resorufin) in a reduced environment (living cells). Fluorescence from the cell assays 
were observed in a fluorescence plate reader. 
4.3.3 NIR Laser Irradiation Control 
Cells prepared as previously mentioned underwent variable duration NIR laser irradiation 
at 32 W cm
-2
 sans nanoGUMBOS. The cells were irradiated for 10, 20, or 30 minutes followed 
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by immediate removal of the media, then washed with PBS, and incubated in AB/DMEM. Assay 
plate readings were performed eight hours after 100 µL addition of AB/DMEM media. 
4.3.4 Hyperthermal Technique 
Cells were prepared as previously mentioned. NanoGUMBOS with final concentrations 
of 77.6, 124.9, and 179.6 µg mL
-1 
were irradiated with a NIR laser (Appendix, Figure A4.5). The 
nanoGUMBOS were incubated for four hours before irradiation preparations. Preparations 
included removal of media, washing cells with PBS, and adding 100 µL of DMEM media to 
each well plate. Each well plate was exposed to continuous NIR laser irradiation for either 10, 
20, or 30 minutes with a laser power density of 32 W cm
-2
. Post irradiation: media was removed, 
cells washed with PBS, and incubated with AB/DMEM media for eight hours prior to measuring 
the fluorescence. 
4.3.5 Fluorescence Microscopy 
 A fluorescence image depicting cell death via hyperthermia was performed by use of 
fluorescence microscopy. A concentration of 250,000 MDA-MB-231 breast cancer cells were 
grown in a 12 well-plate in DMEM and allowed to grow to confluency. The cells were injected 
with 77.6 µg mL
-1 
NIR nanoGUMBOS incubated at 32 °C with 5% CO2. The NIR 
nanoGUMBOS were allowed to incubate for four hours before a 30 minute irradiation. 
Following irradiation the cells were treated with the live/dead assays to exemplify the selectivity 
of irradiation and nanoGUMBOS towards hyperthermia. 
4.3.6 Cellular Uptake 
Cellular uptake of nanoGUMBOS was measured employing modified previous 
methods.
26-27
 NanoGUMBOS (final concentration of 77.6 µg mL
-1
) were injected in 2 mL of 
modified DMEM media with 250,000 MDA-MB-231 cells in a 12 well-plate. The 
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nanoGUMBOS incubated for four hours before the media was removed and saved. The cells 
were washed three times with PBS followed by digestion of the cell walls and dissolution of the 
nanoGUMBOS using 2 mL DMSO. The resulting solution was saved to measure absorbance 
from the GUMBOS against a DMSO-digested cell reference. The absorbance measurements 
were compared to a concentration gradient of variable GUMBOS concentrations dissolved in 
DMSO (Figure 4.1). 
 
Figure 4.1 Concentration absorbance at 1000 nm gradient of percent of 77.6 µg mL
-1
 (A) 
[1048][Folate] and (B) [1061][Folate] nanoGUMBOS in DMSO was used to determine the 
concentration of nanoGUMBOS that entered the MDA-MB-231 cells.  
4.4 Results 
Presently, literature has gravitated towards gold nanomaterials (e.g. shells, particles, and 
rods) in producing heat by NIR laser irradiation for hyperthermia.
30-32
 Herein a new class of 
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materials called NIR nanoGUMBOS demonstrates photothermal generation for a hyperthermal 
cancer therapeutic. The two different NIR nanoGUMBOS, [1048][Folate] and [1061][Folate], 
were used in the study. 
4.4.1 NIR NanoGUMBOS Characterization 
A microwave-assisted reprecipitation method was used to synthesize NIR nanoGUMBOS 
from NIR GUMBOS (Figure 4.2). The TEM micrographs and DLS for [1048][Folate] and 
[1061][Folate] NIR nanoGUMBOS revealed monodisperse particles with very limited 
aggregation (Table 4.1). Nanoparticles will typically be recorded to have a larger size with DLS 
because the instrument measures the average hydrodynamic radius (or slipping plane). The 
hydrodynamic radius is averaged due to particles being in constant Brownian motion from 
solvent and other molecule bombardment. 
 
Figure 4.2 The NIR nanoGUMBOS TEM micrograph shows particle sizes for (A) 
[1048][Folate] at 121 ± 32.5 nm and (B) [1061][Folate] at 144 ± 46.8 nm. 
 
Table 4.1 The NIR nanoGUMBOS were monodisperse under microwave-assisted reprecipitation 
synthesis. 
 
[1048][Folate] [1061][Folate]
(A) (B)
NanoGUMBOS
NanoGUMBOS size (nm)
TEM Micrograph DLS PDI
[1048][Folate] 121  32.5 157  2.4 0.137
[1061][Folate] 144  46.8 176  1.2 0.066
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 The NIR nanoGUMBOS were determined to be 89-93% insoluble after a two week study 
of the particles suspended in water (Table 4.2). The particles were centrifuged for 20 minutes at 
3500 rpm before the top foremost liquid was measured for absorbance (Appendix, Figure A4.6). 
The wavelength chosen to compare absorbance values was determined by the absorbance 
maxima from the controlled NIR nanoGUMBOS concentration. 
Table 4.2 NIR nanoGUMBOS remained significantly insoluble in an aqueous suspension media. 
 
4.4.2 NIR NanoGUMBOS Cytotoxicity 
 
 
Figure 4.3 Viability studies of (A) [1048][Folate] and (B) [1061][Folate] NIR nanoGUMBOS 
using an alamarBlue® assay was performed on breast cell lines. 
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NIR nanoGUMBOS toxicity was determined in a cancerous breast cell line (MDA-MB-
231) and noncancerous breast cell line (HS-578-BST) by an alamarBlue® assay (Figure 4.3). 
The NIR nanoGUMBOS naturally resulted in being toxic to the both cell lines with an increase 
in concentration; however, the NIR nanoGUMBOS were seemingly more toxic to MDA-MB-
231 cells. The median lethal dose (LD50) of NIR nanoGUMBOS was calculated from the slope at 
which the cell viability decreased (Figure 4.4). The LD50 for NIR nanoGUMBOS [1048][Folate] 
in MDA-MB-231 and HS-578-BST cell lines are 158 and 214 µg mL
-1
, respectively. The 
[1061][Folate] NIR nanoGUMBOS LD50 for MDA-MB-231 and HS-578-BST are 123 and 278 
µg mL
-1
, respectively. 
 
Figure 4.4 The LD50 was calculated from the linear slope of the cytotoxicity in different cell 
lines of NIR nanoGUMBOS. 
4.4.3 Laser Irradiation Cytotoxicity 
 Since the late 19
th
 century, it has been known that healthy cells are more robust than 
cancer cells in terms of extreme temperatures.
28, 33
 Unfortunately for that time, the notion of 
robustness was merely a state of observation and not quantification. Irradiating cells was 
performed orthogonally to a 96 well-plate over a set time period. The cells were not influenced 
by NIR nanoGUMBOS in order to observe “cytotoxicity” from only the laser. Laser irradiation 
control supports the previous claims as the normal breast cells retained 93-95% viability after 
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continuous irradiation unlike the cancerous cells which decreased in viability (Figure 4.5). 
Cancer cells are more susceptible to heat due to disorganized cellular structure and functions. 
 
Figure 4.5 Laser irradiation over cancerous MDA-MB-231 (MDAs) and noncancerous HS-578-
BST (BSTs) were observed. 
 
4.4.4 Laser Irradiation Photothermal Response 
There have been many different procedures in the literature on measuring photothermal 
response such as using a NIR thermal camera on brass plate,
34
 confocal fluorescence thermal 
imaging in optofluidic device,
35
 thermocouple in vacuum apparatus,
36
 or thermocouple in a 
sealed cuvette.
37
 In an effort to accurately record the photothermal generation towards a 
hyperthermal therapeutic, a glass NMR tube as the sample compartment was used to mimic the 
conditions cells would experience in a 96 well-plate. Recording hyperthermal generation proved 
difficult in a 96 well-plate due to the laser irradiating the thermocouple directly. The NIR 
nanoGUMBOS were irradiated in 100 µL modified DMEM media for 30 minutes while the 
thermocouple measured photothermal generation (Figure 4.6). NIR nanoGUMBOS 
concentrations for laser irradiation were a result of the viability critical concentrations: 77.6, 
124.9, and 179.6 µg mL
-1
. 
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Figure 4.6 Substantial heat was generated from the NIR nanoGUMBOS (A) [1048][Folate] and 
(B) [1061][Folate]. 
 
 The [1048][Folate] NIR nanoGUMBOS collectively reached a constant photothermal 
generation after 10 minutes of continuous irradiation. After 30 minutes of irradiation 
[1048][Folate] NIR nanoGUMBOS concentrations of 77.6, 124.9, and 179.6 µg mL
-1 
respectively heated to 48.1 ± 4.2, 59.9 ± 1.9, and 57.5 ± 6.2 °C. The [1061][Folate] NIR 
nanoGUMBOS achieving full photothermal potential after 5 minutes also generated more heat 
upon irradiation. The [1061][Folate] NIR nanoGUMBOS of concentrations 77.6, 124.9, and 
179.6 µg mL
-1 
respectively heated to 55.4 ± 4.0, 63.2 ± 2.4, 64.3 ± 2.2 °C. The NIR 
nanoGUMBOS generate heat during the vibrational relaxations after excitation to the first 
excited singlet state. 
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4.4.5 Hyperthermia Cancer Therapeutic 
  
 
 
Figure 4.7 [1048][Folate] NIR nanoGUMBOS with MDA-MB-231 breast cancer cells shows 
live-green and dead-orange controls, nanoGUMBOS control-blue, and hyperthermal (laser and 
nanoGUMBOS)-red at (A) 10 minute, (B) 20 minute, and (C) 30 minute lasing time intervals. 
 
The hyperthermal method was performed by orthogonally placing the laser 2.5 cm above 
the 96 well-plate and irradiating in time increments of 10, 20, and 30 minutes. After the MDA-
MB-213 cells with NIR nanoGUMBOS were irradiated, it was concluded that the 77.6 µg mL
-1 
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concentration under irradiation for 20 – 30 minutes greatly kills tumor cells. Representative 
graphs further compare side-by-side difference in [1048][Folate] (Figure 4.7) and [1061][Folate] 
(Figure 4.8) nanoGUMBOS cytotoxicities, hyperthermia responses, and laser control toxicity 
with MDA-MB-231 cancer cells. 
 
 
 
Figure 4.8 [1061][Folate] NIR nanoGUMBOS with MDA-MB-231 breast cancer cells shows 
live-green and dead-orange controls, nanoGUMBOS control-blue, and hyperthermal (laser and 
nanoGUMBOS)-red at (A) 10 minute, (B) 20 minute, and (C) 30 minute lasing time intervals. 
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The [1048][Folate] nanoGUMBOS in concert with NIR laser irradiation substantially 
killed cancerous cells. It was shown that with an increase in irradiation time and nanoGUMBOS 
concentration the percentage of cell death increased. The concentration of 77.6 µg mL
-1 
and 10, 
20, and 30 minutes irradiation resulted in respective cell death percentages of 70.7, 33.2, and 
12.0%. This concentration would be the ideal use since the nanoGUMBOS control yielded 
90.2% cell viability. 
 
Figure 4.9 A fluorescence microscopy image distinctively shows cell death from the selective 
area where (A) laser irradiation occurred, (B) did not occur, and (inset) cusp of 
irradiation/nonirradiation. (Note: the diameter of the laser spot matches the laser focal spot in 
image, 2 mm.) 
 
 The [1061][Folate] nanoGUMBOS in concert with NIR laser irradiation substantially 
killed cancerous cells at a concentration of 77.6 µg mL
-1
. This concentration with 10, 20, and 30 
A
B
A
B
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minute irradiation resulted in respective cell viabilities of 80.0, 22.6, and 19.2%. After 10 
minutes of irradiation, the nanoGUMBOS control and nanoGUMBOS with irradiation resulted in 
similar cell death not specifying the contribution of the photothermal effects. However, 20 and 
30 minutes irradiation clearly demonstrate the hyperthermal effects (Figure 4.9). The 
fluorescence microscopy image shows the selectivity of cell death when a NIR laser is irradiating 
cancerous breast cells that have incubated nanoGUMBOS. Cells that have died (red 
fluorescence) exhibited ablation resulting in fusion to the well-plate and leading to congregation 
of dead cells; however cells that have died, but not ablated became detached leaving a halo. 
4.4.6 Cellular Uptake of NIR NanoGUMBOS 
 Based on previous literature, the folate molecule has been used for targeting cancerous 
cells allowing nanomaterials to enter cells via receptor-mediated endocytosis. Receptor-mediated 
endocytosis enters cells by attaching to the proper receptor invaginating nanomaterials in the cell 
interior. After performing the method (vide supra) for cellular uptake it was determined that only 
about 6% of the injected (77.6 µg mL
-1
) entered the MDA-MB-231 cells (Table 4.3). 
Confirmation of the cellular uptake was performed by calculating the theoretical percent by 
comparing the absorbencies of a controlled 10% nanoGUMBOS dissolved in DMSO and 
samples, and the sample absorbance with the slope equation from the concentration gradient. The 
two respective values show a 96.9% and 92.2% agreement for [1048][Folate] and [1061][Folate], 
respectively, when performing the calculations. 
Table 4.3 The percent of nanoGUMBOS were calculated by difference in absorbance from the 
control (10% dissolved in DMSO) and from the concentration gradient equation (%Slope). 
 
 
NanoGUMBOS Sample Wavelength (nm) Absorbance %Overall Uptake %Slope
Cells 0.004986
DMSO (10%) 0.007864
Cells 0.002146
DMSO (10%) 0.003808
[1048][FA] 1000 6.34 6.15
[1061][FA] 1000 5.64 6.12
113 
 
4.5 Conclusion 
The [1048][Folate] and [1061][Folate] NIR nanoGUMBOS successfully destroyed via 
hyperthermia the MDA-MB-231 breast cancer cells when photothermal generation was activated 
by 1064 nm NIR laser irradiation despite. NIR nanoGUMBOS without photothermal generation 
showed little toxicity to both cancerous and noncancerous (HS-578-BST) breast cells. While 
both NIR nanoGUMBOS were successful in killing cancer cells by hyperthermia, neither 
nanoGUMBOS were lesser effective in killing when irradiated for more than 20 minutes. These 
types of NIR nanoGUMBOS have thus demonstrated the applicability as a hyperthermal 
therapeutic towards cancer therapy. 
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Chapter 5. Conclusion and Future Studies 
5.1 Concluding Remarks 
GUMBOS and nanoGUMBOS have great promise towards a facile fabrication of task-
specific materials. This monograph exemplified just a minute fraction of the possibilities that 
GUMBOS can perform, such as lanthanide-based luminescent nanoGUMBOS and photothermal 
NIR nanoGUMBOS as a hyperthermal cancer therapeutic.  
Lanthanide nanoGUMBOS luminescence had high intensity at 613 nm as GUMBOS 
dissolved in ethanol. However, the lanthanide luminescence intensity decreased as 
nanoGUMBOS due to quenching from the imidazolium cation fluorescence at 420 nm. The 
imidazolium cation contributed to FRET when dissolved, but as nanoGUMBOS the imidazolium 
produced fluorescence. In addition to the luminescent spectrum, this was supported by energy 
transfer efficiency of GUMBOS having higher efficiency verses the nanoGUMBOS at 65.7% 
and 7.48%, respectively. 
NanoGUMBOS were also synthesized with NIR cations (i.e. [1048] and [1061]) and 
biocompatible anions (i.e. [Ascorbate], [Deoxycholate], and [Folate]). While the anions, 
[Ascorbate] and [Deoxycholate], were used to demonstrate the feasibility of photothermal 
efficiency; the [Folate] anion was used as a hyperthermal cancer therapeutic towards the 
destruction of breast cancer. The formerly mentioned anions were found to be generous in 
efficiently converting laser irradiation to thermal generation. A trend shows nanoGUMBOS 
having [1048] cation and nanoGUMBOS having [Ascorbate] anion being more efficient in 
converting light to heat than [1061] cation and [Deoxycholate] anions, respectively. 
NIR nanoGUMBOS were used towards breast cancer therapy by hyperthermal methods 
was used. Capable of reaching temperatures around 60 °C, NIR nanoGUMBOS successfully 
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destroyed cancer cells without cytotoxicity prior to laser irradiation. Concentrations of 77.6 µg 
mL
-1 
NIR nanoGUMBOS and 20 minutes irradiation yielded cell death equivalent to the dead 
control. 
 Throughout history there have been many giant leaps in scientific research that has 
advanced current research from tasting molten salts to light amplification by stimulated emission 
to manipulating molecules to perform work. NanoGUMBOS exemplify material that is easily 
tunable for a task-specific application opposed to solely being used as a solvent. 
5.2 Future Studies 
 Organic light emitting diodes (OLED) have become of great interest since an intense 
green emission from aluminum tris(8-hydroxyquinolinate) in 1987. It was not long before OLED 
research used lanthanide complexes. In 1990, a terbium (III) tris(acetylacetonate) complex was 
used as the emissive layer. A basic single-layer OLED device is made up of three main 
components: an anode (e.g. Indium Tin Oxide), organic emitting compound, and a cathode (e.g. 
Ca, Mg, or Al). Multiple-layer OLED devices employ electron and/or hole transport media such 
as 2-(4-biphenyl)-5-(4-tert-butylphenyl)-1,3,4-oxadiazole and N,N-diphenyl-N,N’-bis(3-
methylphenyl)-[1,1’-biphenyl]-4,4’-diamine, respectively. These electron transports correspond 
to the conduction band (LUMO), while hole transports correspond to the valence band (HOMO).  
Due to the ability to combine properties using GUMBOS, it would be interesting to use an 
electron or hole transport cation with the previously designed lanthanide anion. 
 Electron transport molecules that would be synthesized into a cation would be 
bathocuproine due to its efficient electron injection thus giving higher quantum efficiency. The 
europium (III) tetra(beta-diketonate) would be the acting emissive layer and anion. These 
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lanthanide nanoGUMBOS would have a greater surface area which would result in more intense 
radiative emissions from the europium. 
There have been many types of nanomaterials employed for hyperthermal cancer 
therapeutics that have used in vivo mouse models to demonstrate the success of tumor reduction. 
It would be paramount for the NIR hyperthermal nanoGUMBOS effectiveness to be studied 
using SCID (severe combined immunodeficiency) mice with artificially grown MDA-MB-231 
cancer tumors. The study would include the three studied concentrations from the in vitro studies 
(77.6, 124.9, and 179.6 µg mL-1 per 0.1 cm3 of the tumor). The tumor would be measured pre-
nanoGUMBOS injection for its volume followed by the corresponding injection of NIR 
nanoGUMBOS. Laser irradiation would be set at 1000 mW and use a continuous irradiation for 
10, 20, and 30 minutes. The mice tumors would be studies using NIR nanoGUMBOS controls, 
NIR laser irradiation controls, and a combined study. 
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Appendix 1. Supplemental Information for Chapter 3 
Chapter 3 - Photothermal Response of Near-Infrared NanoGUMBOS 
A.) [1048][BF4] 
 
 
 
 
B.) [1048][Deoxycholate] 
 
 
Figure A3.1 
1
H and 
19
F NMR of the GUMBOS in d-DMSO. 
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C.) [1048][Ascorbate] 
 
 
 
 
Figure A3.1 Continued. 
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D.) [1061][BF4] 
 
 
E.) [1061][Deoxycholate] 
 
 
Figure A3.1 Continued. 
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F.) [1061][Ascorbate] 
 
 
 
Figure A3.1 Continued. 
 
 
 
 
 
 
 
124 
 
A.) [1048][Deoxycholate] 
 pH 2 & 5 
 
  
pH 7, 9, & 11 
 
B.) [1048][Ascorbate] 
 
 pH 2 
 
 
 
 
Figure A3.2 FT-IR of the nanoGUMBOS synthesized in different pH media suggests that the 
material is deprotonated with an increasing pH media. 
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 pH 5, 7, & 9 
 
 
 pH 11 
 
Figure A3.2 Continued. 
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C.) [1061][Deoxycholate] 
 
 
pH 2 & 5 
 
  
pH 7, 9, & 11 
 
 
 
D.) [1061][Ascorbate] 
pH 2 
 
 
Figure A3.2 Continued. 
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Figure A3.2 Continued. 
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pH 11 
 
 
 
Figure A3.2 Continued. 
 
 
  
94
95
96
97
98
99
100
600110016002100260031003600
Tr
an
sm
it
ta
n
ce
 %
Wavelength (nm)
[1061][Ascorbate] pH11
-C=O
-C=C- -C(=O)-O-C-
-C-O- (chain)
-C-O- (ring)
-CH
-OH
-C-OH
 
 
129 
 
Appendix 2. Supplemental Information for Chapter 4 
Chapter 4 - Tumor-Targeting Hyperthermal Near-Infrared NanoGUMBOS 
 
Figure A4.1 ESI MS of the folate product after synthesis reveals that the folic acid precursor is 
higher in concentration by two fold. (The inset is a scan on only the folate.) 
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Molecular Weight: 441.40
Folate
Molecular Weight: 463.38
Molecular Weight: 463.38
m/z: 463.12 (100.0%), 464.12 (23.1%), 465.13 (3.3%)
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Figure A4.2 
19
F NMR was used to observe the anion exchange from the anion precursor [BF4] to 
non-fluorinated product [Folate] for the (A) [1048] and (B) [1061] GUMBOS. 
[1048][BF4]
[1048][Folate]
A
[1061][BF4]
[1061][Folate]
B
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Figure A4.3 Photothermal measurements were recorded by a thermocouple placed about 2 mm 
above the laser beam. 
 
Figure A4.4 Incubation of eight hours for 10,000 cells with the alamarBlue® assay was 
preferred due to the higher fluorescence intensity and smaller standard deviation. 
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Figure A4.5 In vivo hyperthermal experiments were conducted in a 96 well-plate. 
 
Figure A4.6 Absorbance measurements were conducted for comparison of a fixed concentration 
(32 µg mL
-1
) and of the top aqueous layer of post-centrifugation nanoGUMBOS. (A) 
[1048][Folate] was calculated to be 92.92% insoluble, and (B) [1061][Folate] was calculated to 
be 88.75% insoluble. (Note: Absorbance shoulder between 1150-1200 nm was determined to be 
from the folate anion.)  
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